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Neuropeptide Y (NPY) has been long studied in the realms of stress, feeding, 
and drugs of abuse, including alcohol and NPY’s ability to blunt consumption. A major 
region of importance to this peptide is the Central amygdala (CeA), a predominantly 
GABAergic region. NPY is predominantly expressed in GABAergic populations and 
blunts ethanol (EtOH) consumption by signaling through the NPY1 receptor (Y1R). 
CeA connections to the lateral habenula (LHb), known for anti-reward processing 
through interaction with the tail of the ventral tegmental area (VTA) which is called the 
rostromedial tegmental (RMTg) area. Interestingly, this circuit has not been studied in 
relation to early stages of binge alcohol consumption. Using cre-dependent designer 
receptors exclusively activated by designer drugs (DREADDs) in vgat-ires-cre and 
npy1r-cre mice lines, we discovered that chemogenetic inhibition of the GABAergic 
population to the LHb from the CeA significantly blunted binge-like consumption of 
20% EtOH and did not blunt the binge-like consumption of 3% sucrose. Chemogenetic 
inhibition of this same pathway in the npy1r-cre mice targeting Y1R+ neurons also 
showed this significant blunting of binge-like EtOH consumption without effects on 
sucrose intake. Using two different chemogenetic inhibitory viruses, one cre-
dependent, targeted at the CeA to LHb pathways, and one neuronal dependent, 
targeting the RMTg which is downstream of the LHb and thought to drive this reduction 
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in EtOH intake, we attempted to investigate the complex CeA → LHb → RMTg circuit 
in modulating binge-like ethanol intake. No effects on EtOH nor sucrose intake were 
seen in any of the viral combination group combinations of CNO and SalB compared 
with combination two vehicles. Overall, there was no effect of inhibition of Y1R+ CeA 
projection neurons to the LHb, simultaneous inhibition of Y1R+ projection neurons to 
the LHb and the RMTg, or of solo inhibition of the RMTg. Finally, ex vivo 
electrophysiology techniques were used to see if a brief cycle of binge-like EtOH 
consumption resulted in changes of physiological properties of spontaneous inhibitory 
postsynaptic currents (sIPSC) in these LHb-projecting Y1R+ neurons in the CeA. No 
differences were observed between EtOH-exposed animals and water controls. We 
also probed if exposing these neurons to acute EtOH during recording would produce 
more excitatory responses in neurons of animals exposed to EtOH. No such 
differences were observed. We also tested NPY administration on these neurons and, 
while underpowered, it would seem that sIPSC amplitude may be altered in EtOH-
exposed animals. We are also underpowered in our cell-attached recordings looking 
as baseline firing rates in these neurons; but preliminary results lean toward an 
increase in firing rate in EtOH-exposed animals. Overall, we found that inhibiting LHb-
projecting GABAergic and YR1+ neurons in the CeA blunts binge-like consumption of 
EtOH but not sucrose. This could indicate an important circuit controlling alcohol 
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In a class commonly known as alcohol, ethanol (EtOH) is the specific type that 
has been utilized throughout human history for its byproducts and psychoactive 
properties. Alcohol is obtained through fermentation, a process where yeast 
metabolizes sugars creating both carbon dioxide and EtOH. This can be seen with 
plant products that are stored for an extended period of time in a stable environment. 
The earliest connection to the fermenting of alcohol can be found as early as about 
10000 BCE (Partick, 1952). It is believed that mead and barley wine, made from honey 
and fruits, started as early as 7000 BCE (Chrzan, 2013). Not only has alcohol been 
used as a means of intoxication but it has also been used as a means of promoting 
fluid intake and caloric intake, for various social settings, a valuable form of trade and 
medicinal use of alcohol can even be seen in various religious text (Alcock, 2006; 
Chrzan, 2013). It is still a prominent staple of many societies for many uses ranging 
from ceremonies, parties, and stress-relief. 
During the 20th century, alcohol had become the target of newly empowered 
religious groups within the United States due to its relation to partying and frivolity. 
This led to the enactment of the 18th Amendment which prohibited producing, sale, 
and transport of alcohol. The state in history in call the “Prohibition” era and the 
beginning of many large crime organizations and hidden bars called a “Speak-easy”. 
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This amendment did little to influence the use of alcohol and was later overridden with 
the passing of the 21st Amendment with the United States and once again bringing 
alcohol back into cultural-acceptability where is has remain ever since and is being 
seen to have negative consequences associated with excessive use.  
Alcohol Use and Abuse 
 When looking at consumption of alcohol in low to moderate levels, much of the 
research does not definitively link extreme negative consequences to these drinking 
patterns (Leroi et al., 2002; Gunzerath et al, 2004). However, with excessive alcohol 
use this is not the case. Numerous health issues associated with the heavy alcohol 
consumption; some of which include heart and pulmonary disease, numerous 
cancers, liver disease and cirrhosis, mental health disorders, and other injuries 
((WHO), 2018; Rehm et al., 2009; Room et al., 2005). In fact, excessive alcohol use 
is responsible for over 95,000 deaths and an average lifespan shortening of almost 
29 year equaling about 2.8 million years of life lost (Esser et al., 2020). In 2017, 86% 
of adults within the United states had reported using alcohol within their life and over 
50% reporting in the last month (SAMHSA, 2017). Excessive ethanol drinking is of 
concern in the military population, college graduate community, and within all 
categories of socioeconomic populations (Waller et al, 2015; Rutledge et al, 2016; 
Esser et al., 2014) Alcohol dependence among excessive drinkers has been seen to 
be around 10.2% (Esser et al., 2014). 
 The further one continues down this road of excessive alcohol consumption, 
the more likely it is to begin interfering with personal relationships, working 
environment, financial situation, and more. At this point, there is a large possibility that 
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this excessive drinking has developed into an alcohol use disorder (AUD). An AUD is 
the current diagnosis, which is a combination of separately defined diagnoses, defined 
in The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) taking into 
account interference with work and social life, craving for alcohol, tolerance, an 
inability to stop even despite negative consequences, and so on (American Psychiatric 
Association, 2013). Through this new definition, AUD severity can be categorized into 
mild (2 to 3 symptoms), moderate (4 to 5 symptoms), or severe (≥ 6 symptoms) based 
on a list of 11 symptoms provided in the DSM-5, making the diagnosis of this disorder 
more of a spectrum-based one. In 2017, there were a reported 14.5 million Americans 
who met enough criterion to fall somewhere on the AUD spectrum (SAMHSA, 2017). 
Even with this much of the population suffering from AUDs, there are very few FDA-
approved treatments available and even those available are not always effective for 
all patients. This makes uncovering the neurobiological basis of alcohol use a major 
area of concern in order to uncover pharmacological and system wide approaches to 
treat and manage AUDs in the people who live with them.  
Binge alcohol consumption 
 One of the most abundant forms of excessive alcohol use in the world is binge 
drinking. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) defines 
binge drinking as a pattern of consumption that produces blood ethanol concentrations 
(BECs) greater than 0.08% (80 mg/dL) within a short period of time (NIAAA, 2004). In 
a general speaking, for men, that equates to about 5 drinks and, for women, about 4 
drinks consumed within a 2-hour period. Much of what has been studied in the human 
population has focused within a young adult, undergraduate population; however, 
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these alarming rates of binge alcohol consumption occur throughout the human 
lifespan (Hingson et al., 2005; Miller et al., 2007; Fan et al., 2008). In fact, 90% of 
excessive drinking adults within the United States consume alcohol in a binge form 
(Esser et al., 2014) This form of excessive alcohol consumption has been heavily 
linked to the transition and development of AUDs (Rubinsky et al., 2010). The 
prevalence of alcohol dependence has been seen to be 10.5% in binge drinkers which 
is slightly higher than that of overall excessive drinkers (Esser et al., 2014). In 2015, 
17.1% of adults in the United States reported binge drinking. This equated to about 
53 binge episodes of alcohol consumption with an average of 7 drinks per episode; if 
totaled would equal 467 drinks per drinker (Kanny et al., 2018). Even more shocking 
is the staggering economic costs that the United States faces each year in alcohol 
related cost which total $249 billion dollars and over 75% of that costs being 
associated with binge consumption, equating to $191 billion in annual costs (Sacks et 
al., 2015). These costs encompass injury, health cost, death, lost wages and labor 
force, and government spending on treatment and prevention, the latter of which 
encompasses a very small portion of these costs. This makes this particular form of 
drinking a major concern for study and it demonstrates a vital need to discover viable 
targets for therapeutic treatment and maintenance. 
Preclinical models of ethanol consumption 
 Given that AUDs are complex and that criterion met by one person under this 
diagnosis can greatly differ from that of another, there have been multiple preclinical 
models of alcohol-related behavior in order to understand this complex subject. This 
has been necessary in order to be able to use differing models in answer questions 
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based around the different criterion within the DSM-5. Some of these models 
reproduce the induction of excessive binge-like alcohol intake through the method of 
intraperitoneal injection (i.p.), vapor, or gavage (Turner et al., 1998; Chen et al., 2013; 
Goldstein and Pal,1971). Though these methods due all produce BECs in excess of 
the required threshold that is binge-like intake (80mg/dl) they lack face validity in the 
assessment of alcohol use. A model that could better demonstrate this self-
consumption is operant self-administration which has been utilized in both rat and 
mouse models and is a reliable way to break apart seeking and consummatory 
behaviors; however, “forced” abstinence or induction through injection or vapor seems 
to be necessary in order to see excessive consummatory behavior in rats and those 
done in mice do not see an increased intake (O’Dell et al., 2004; Becker and Lopez, 
2005; Roberts et al., 2000; Spanagel and Holter, 1999; Bell et al., 2004; Khisti et al., 
2006). Another possible self-consumption model is the two-bottle choice paradigm, 
where researchers introduce an EtOH and non-EtOH solution simultaneously 
(Tabakoff and Hoffman, 2000). The problem with this model is that most have not 
found binge-equivalent BEC production and in true nature this model better represents 
that of a preference assessment (Spanagel, 2000). Overall, these models either need 
excessive amount of time and drinking history and/or non-self-consumption methods 
of alcohol administration to produce binge-equivalent BEC consumption if it is 
achievable at all.  
Drinking-in-the-dark 
The neural mechanisms underlying this dangerous behavior can be studied in 
rodents through the 4-day “drinking in the dark” (DID) model of ethanol consumption 
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(Rhodes et al., 2005; Thiele and Navarro, 2014; Thiele et al., 2014; Holgate et al., 
2017). With this model, excessive alcohol consumption can be achieved along with 
reliable BECs in excess of the binge threshold set by the NIAAA. This paradigm 
utilizes a time at the beginning of the rodent wake-cycle, which is nocturnal in rodents, 
when general consummatory behavior is high (Ho and Chin, 1988; Tabarin et al., 
2007). Even more impressive is that this observed EtOH consumption in not due to 
caloric need (Lyons et al., 2008). This model of consumption is generally used to study 
the onset of excessive drinking prior to dependence. This is due to the fact that this 
model has not been seen to lead to the development of dependence-associated 
behaviors even after multiple cycles of the paradigm extending out up to 10 weeks 
(Cox et al., 2013). 
During the dark cycle on days 1-3, the water bottle is replaced with 20% 
volume/volume (v/v) ethanol solution three hours in the dark cycle and remain for a 
duration of two hours before EtOH is removed and water bottle are returned. On day 
4, termed the test day, functions much the same as the first three days with a few 
alterations; prior to EtOH access drug treatment can be administered, access to EtOH 
can be extended to up to 4 hours in order to achieve higher BECs, and after EtOH 
bottles are removed tail blood samples are collected to assess plasma BEC levels. 
Since this method allows the animal to freely drink and is easily altered due to its 
simplicity it is the preferred method to use when studying animal models of binge-like 
intake. With this model researchers are able to gain insight into how voluntary, binge-
like consumption of high levels of ethanol affects functioning of neuromechanisms and 
circuitry to better understand how this type of consummatory behavior may contribute 
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to the development of an alcohol use disorder (AUD). Yet, the mechanisms and 
circuitry within the brain that are responsible for this consumption pattern have gone 
widely unstudied. 
Chemogenetic Tools 
 Chemogenetics provides a remote method for reversable cell control, of overall 
population or specific circuitry, through injection of a specific ligand for activation 
(Alexander et al., 2009). This method could be seen as similar to optogenetics that 
utilize uses opsins in order to control cellular function via light. What makes this 
activation by ligands different is the lack of need for tethers and wires for light 
activation providing easier manipulation with relation to behavior, though 
chemogenetics do not show as high of a temporal resolution. This ease of use could 
also make for an easier transition to therapeutical treatment in human models. There 
have been numerous different chemogenetic receptors engineered over the years with 
different types of G-protein coupled receptors (GPCRs) and ion channels (Strader et 
al., 1991; Coward et al., 1998; Lechner et al., 2002 Dong et al., 2010; Lerchner et al., 
2007; Magnus et al., 2011).  
The chemogenetic method that has gained the most attention and traction in 
the field are mutated from the human muscarinic GCPRs and are coined, Designer 
Receptors Exclusively Activated by Designer Drugs (DREADDs) (Dong et al., 2010). 
These receptors are no longer reactive to the endogenous ligand, acetylcholine (Ach) 
and is only reactive to designer ligands such as clozapine N-oxide (CNO), compound 
21, and perlapine (Armbruster et al., 2007; Chen et al., 2015; Roth, 2016). The 
mutated muscarinic GPCRs come in three forms and are Gq, Gs, and Gi. Generally 
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speaking, the first two are utilized to increase neuronal firing; though Gq-coupled, 
which stimulates phospholipase C leading to a release in intercellular calcium (Ca+), 
is the more commonly used excitatory DREADD versus Gs-coupled, which stimulates 
cyclic adenosine monophosphate (cAMP). The Gi-coupled DREADD is the inhibitory 
GPCR and works by inhibiting cAMP production (Urban and Roth, 2015). Since this 
group of receptors react to the same designer ligands, it is only possible to study one 
at a time with one population or circuit. This need for a separate DREADD that could 
be utilized in unison with the others drove the creation of the fourth, the inhibitory κ-
opioid receptor DREADD (KORD). The KORD is activated by the inert ligand 
salvinorin B (SalB) which is very selective for this receptor with little to no outside 
binding and effect (Vardy et al., 2015). The ability to use dual DREADD manipulation 
within circuitry, same call populations, or multiple cells population within a circuit or 
brain region allows further studies the ability to expand understanding by taking 
advantage of these various multiplexing techniques.  
DREADDs have already proven to be a useful tool in research (Cheng and 
Wang, 2019). Through this functional tool in combination with transgenic animal 
models, such as cre-lines, studies have been uncovering regions, specific cell 
populations, circuitry, feedback loops, and molecular mechanisms involved with 
multiple models of consumption, administration, dependence, and withdrawal of 
alcohol. 
Neuropeptide Y 
Neuropeptide Y (NPY) is a 36-amino-acid polypeptide belonging to the 
neuropeptide tyrosine family (Allen et al., 1986). It is known as the most abundant 
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peptide in the CNS and tends to predominantly co-express within GABA-ergic 
interneurons.  It is stored in large dense core vesicles at nerve terminals (Hokfelt, 
1991; Hokfelt et al., 1980). There are six receptors associated with NPY which are 1-
6; however, Y6R is not expressed in the rodent brain and Y3R has yet to be cloned. 
Once NPY binds to these receptors, it exerts its action by inhibition of cAMP 
production while diminishing Ca+ channel activity and enhancing G-protein coupled 
inward rectifying potassium (K+) channel currents (Acuna-Goycolea et al., 2005; 
Palmiter et al., 1998).  
Much research has been dedicated into understanding NPY function and 
circuitry as it pertains to stress and emotion, feeding behavior, neural development, 
reward, sleep, learning and memory. (Heilig, 2004; Leggio et al., 2011; Allen et al., 
1986; Bouali et al., 1995; Palmiter et al., 1998; Caberlotto and Hurd, 1999; Stanley et 
al., 1985). And when you look at the vast distribution of this peptide and receptors, it 
is not surprising that NPY is involved in so many functions and responses (Allen et al., 
1989; Dumontet et al., 1993; Gotzsche and Woldbye, 2016; Kopp et al., 2002; Palmiter 
et al., 1998; Parker and Herzog, 1999; Roberto et al., 2012).  
Given the relation to stress and increased risk of drug and alcohol abuse; NPY 
plays a very interesting role in the stress response by counteracting with the 
predominantly pro-stress peptide, corticotropin-releasing factor (CRF) especially in 
stress-related brain regions (Valdez and Koob, 2004; Kash and Winder, 2006). CRF 
is known to cause anxiogenic phenotypes and NPY acts as the opposite causing 
anxiolytic responses. In a vast range of animal behavior paradigms associated with 
stress including conflict tests, elevated-plus maze (EPM), light-dark box, social 
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interaction, and startle NPY has been shown to produce an anti-stress or anti-anxiety 
like behavior (Heilig et al., 1989; Heilig et al., 1992; Pellow et al., 1985, File, 1980, 
Broqua et al., 1995; Pich et al., 1993). Some of the most interesting studies have seen 
that NPY central administration results in sedative-like EEG synchronization and 
intracerebroventricular (i.c.v.) administration of NPY shows decreased overall EEG, 
particularly in amygdala and cortical areas, resembling the sedative activity of 
benzodiazepines (Fuxe et al., 1983; Ehlers et al., 1997). Literature has also 
highlighted the importance of this peptide in reward processing by showing that when 
NPY in infused into the NAcc shell an in vivo increase in DA is observed though 
microdialysis (Sorensen et al., 2009). Chemogenetic activation of NPY neurons within 
the NAcc shell has also been seen to promote an anxiolytic phenotype (Yamada et 
al., 2020).   
Effects of Alcohol on NPY 
EtOH and NPY have a very interesting relationship. This can be seen with an 
electrophysiological study that discovered EtOH and NPY were able to substitute for 
each other and when applied together have an additive effect (Ehlers et al., 1998). 
While interesting, this in not unintuitive given NPY and its ability to cause 
benzodiazepine-like effects as discussed above.  The literature based around the 
topic of EtOH and its effects on NPY varies based on different factors ranging from 
brain region to the amount of consumption. Acute EtOH exposure has been seen to 
show an overall decrease in NPY and NPY mRNA expression as well as NPY 
expression (Kinoshita et al., 2000). This reduction in NPY expression following EtOH 
consumption has also been seen in the NAcc (Barkley-Levenson et al., 2016). A low 
 
11  
diet of EtOH in rats also shows this reduction in NPY in the hippocampus and cortex 
(Bison and Crews, 2003); however, at too low of an EtOH diet this reduction is not 
observed (Ehlers et al., 1998). This effect on NPY seems like it could depend on 
factors such as amount of EtOH consumed, time consumed and region. 
Animals in withdrawal from chronic exposure show this biphasic effect in areas, 
such as the amygdala and hippocampus, where acute withdrawal results in an 
upregulation in NPY; however, in extended withdrawal this shifts to a downregulation 
of NPY overall or a zero-change result in some cases (Barkley-Levenson et al., 2016; 
Roy and Pandey et al., 2002; Zhang and Pandey, 2003; Criado et al., 2011; Bison and 
Crews, 2003). 
Effects of NPY on alcohol-related behavior 
NPY deficiency in mice results in an increase in EtOH consumption while 
decreasing the sedative effects and resulting in a faster EtOH-induced sleep recovery. 
At the same time overexpression of NPY results in the inverse (Thiele et al., 1998; 
Thiele et al 2000) NPY deficiency in mice also leads to an elevated anxiety-like 
phenotype following EtOH exposure (Sparta et al., 2007). NPY blocks operant 
responding increases for ethanol and decreases baseline GABAergic transmission 
(Gilpin et al., 2011). It has also been shown that overexpression of NPY can lead to 
more exacerbated negative side-effects associated with ethanol such as sedation and 
withdrawal (Thiele et al., 1998).  An i.c.v. dose of NPY has been shown to decrease 
binge-like consumption of EtOH (Sparrow et al., 2012). Within the extended amygdala 
NPY has been seen to suppress CRF leading to a reduction in binge-like EtOH 
consumption (Pleil et al., 2015).  
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The genetically inbred C57BL/6J, which displays a high consumption of EtOH 
and generally used for binge-like intake models, has an overall lower baseline in NPY 
expression than the DBA/2J mice, who are the counterpart to the C57BL/6J and show 
an avoidance of EtOH consumption (Hayes et al., 2005). This same observation is 
seen in the alcohol-preferring (P) rats versus their counterparts, the alcohol non-
preferring (NP) rats (Ehlers et al., 1998; Hwang et al., 1999).   Central administration 
of NPY leads to a decrease in EtOH intake and administration in P animals; but not in 
NP or wildtype animals (Badia-Elder et al., 2001; Badia-Elder et al., 2007; Gilpin et 
al., 2008; Henderson and Czachowski, 2012). What is interesting about these alcohol 
phenotype lines created is that the differences in NPY expression seem to be selective 
to areas of emotion and stress, including the amygdala and NAcc, and not 
hypothalamic areas involved with feeding (Ehlers et al., 1998; Hayes et al., 2005; 
Mirsa and Pandey, 2006). In fact, if NPY is infused into the hypothalamic region 
increases EtOH intake and preference (Kelley et al., 2001).  
NPY1 receptor 
The Y1R is one of the main receptors that mediates the effects of NPY. While 
NPY also has affinity for Y4R and Y5R, many studies show that the same anxiolytic 
behavioral effects caused by NPY administration are also seen with Y1R agonism, 
with an unlikely involvement of Y4R (Heilig et al., 1989; Heilig et al., 1993; Asakawa 
et al., 1999). Y5R via antagonism has been seen to have no effect on anxiety-related 
tasks (Kask et al., 2002). It is thought that Y5R acts in unison with Y1R in certain brain 
regions to cause that same effect. Within numerous anxiety-related behavioral 
paradigms, Y1R has been shown to mediate anxiolytic behavior in a postsynaptic 
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fashion (Britton et al., 1997; Heilig et al., 1989; Heilig et al., 1993). Within a Y1R 
knockout model there in no NPY-induced sedation present (Naveilhan et al., 2001). In 
opposition to the effects of Y1R, Y2R is expressed post-synaptically and acts as an 
auto-receptor blocking the release of endogenous NPY from the NPY cell (Chen et 
al., 1997; Greber et al., 1994; King et al., 1999; King et al., 2000). Given this relation, 
much of the Y1R effects through agonists or NPY itself can be recreated through 
antagonism of the Y2R.  
NPY1 receptor involvement with alcohol 
Since previous findings with NPY effects on alcohol-related behavior and 
consumption showed the same directional effect as NPY on anxiety and stress-like 
behaviors it would make sense that effects seen with EtOH on NPY and NPY on EtOH 
are mediated through the Y1R, same as with anxiolytic-like behavior. It is shown that 
Y1R plays an important role in initial sensitivity to alcohol (Chen et al., 2008). In a 
mouse Y1R knock-out, there was seen to have an overall increase in EtOH 
consumption when compared to wild-type mice (Thiele et al., 2002) This study 
highlights that the Y1R is important for the NPY-mediated reduction in alcohol drinking 
as mentioned before. It has also been shown that just as with stress studies Y5 does 
not seem to have a large involvement in relation to alcohol (Thiele et al., 2000). Y1R 
agonism in the medial prefrontal cortex (mPFC) also seems to reduce binge-like EtOH 
consumption. The same study also replicated that effect by chemogenetically 
inhibiting Y1R-expressing neruons within the mPFC (Robinson et al., 2019). In 
another study selective antagonism of Y1R peripherally and centrally reduces EtOH 
consumption (Sparta et al., 2004). This, however, is consistent with effects on the 
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hypothalamic NPY system. Meanwhile, Y1R agonism, centrally administered, causes 
a reduction in binge-like EtOH consumption (Sparrow et al., 2012). This is further 
evidence of the differential effects of NPY and Y1 manipulation within areas related to 
emotion, reward, and stress versus NPY and Y1 manipulation in areas associated 
with feeding behavior. An antagonism of the Y2R has been shown to reduce ethanol 
self-administration in rat models while Y1R manipulation does not seem to have an 
effect on appetitive behaviors, such as level pressing, unless animals are dependent 
on EtOH (Thorsell et al., 2002; Thorsell et al., 2005). Within dependent rat models a 
reduction in self-administered drinking with doses of a Y2R antagonist that are 
ineffective in nondependent models occurs (Rimondini et al., 2005). It seems that the 
Y1R activation/Y2R blockade action on stress and drinking show the same directional 
effects; though is seems that appetitive behaviors remain a bit elusive in relation to 
Y1R and Y2R manipulation. When NPY in the extended amygdala was able to blunt 
binge-like EtOH consumption by inhibiting CRF signaling, it did so through activation 
of the Y1R (Pleil et al., 2015). 
The Amygdala and Central Amygdala  
The overall amygdalar complex in highly differentiated and involved in 
numerous complex behaviors; including sensory, emotional, and autonomic. The CeA 
serves as a major output center for the overall amygdala complex, consisting of a 
predominantly gamma-Aminobutyric acid (GABA)-ergic neuronal population that 
projects to many higher-order and brainstem regions (Swanson and Petrovich, 1998). 
This region is important with drugs of abuse but, also, many other co-morbid mood 
and other mental disorders (Price and Drevets, 2012). Many labs, including our own, 
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have found that the extended amygdala overall, which consists of the central and 
medial amygdala, sublenticular substantia innominata, the NAcc shell, and the bed 
nucleus of the stria terminalis (BNST), is a region of the brain that is particularly 
affected by ethanol (Koob, 2003). This overall area, and the sub-regions within it, have 
also been shown to play an important role in the consumption of ethanol itself (Hyytiä 
and Koob, 1995; Gilpin et al., 2011; Pleil et al, 2015; Rinker et al., 2016) As mentioned 
before, NPY’s benzodiazepine-like electroencephalogram (EEG) decrease and 
sedative-like phenotype seemed to be partially driven by the amygdala (Ehlers et al., 
1997). It is also known that many anxiety disorders are accompanied with hyperactivity 
or hyperreactivity within the CeA (Shin and Liberzon, 2010). The CeA is also dense in 
stress-related neuropeptides. 
Alcohol and stress peptide action in central amygdala 
Electrophysiological research has shown that ethanol enhances GABAergic 
transmission at both pre- and post-synaptic locations within the CeA (Roberto et al., 
2003). It also seems that EtOH is able to augment GABA within the CeA via CRF1 
receptors (CRF1R) (Nie et al., 2004). In a binge-like drinking model the CRF signaling 
in the CeA is recruited during EtOH drinking (Lowery-Gionta et al., 2012). NPY 
opposes EtOH effects on GABA release and blocks a transition to alcohol dependence 
(Gilpin et al., 2011). These findings, along with NPY’s action in the extended amygdala 
on CRF, seem to be showing that Y1Rs act as a brake system on CRF release and 
stop the stress activation thus creating an anxiolytic phenotype. Given the trend we 
have seen with NPY and the Y1R within stress and emotion-related brain regions 
versus the effects in major feeding areas, it is no surprise that the peptide and the 
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receptor show majority of their anxiolytic effects by signaling within the amygdala and 
in the subregion of the CeA. When virally-mediated NPY modulation is used to 
overexpress NPY within the CeA, there is a reduction in ethanol self-administration in 
P rats (Primeaux et al., 2006). 
 GABA release within the CeA is increased in alcohol-dependent rats (Roberto 
et al, 2004). Infusion of NPY into the CeA reduces self-administration in alcohol 
dependent rats while having little effect on behavior in non-dependent (Gilpin et al., 
2008). A history of binge-like EtOH intake results in a decrease in NPY protein 
expression and Y1R within the CeA (Sparrow et al., 2012). Within this same study it 
was shown that, within the CeA, after a history of binge-like EtOH consumption 
resulted in a facilitation of NPY-induced inhibition of GABA-ergic transmission. Further 
study of NPY and its actions at Y1R are need within the CeA in order to know 
downstream targets and to better understand the possible protective effects it has 
against alcohol abuse. 
The lateral habenula 
The habenula is one of the oldest conserved brain regions in almost all 
vertebrate species (Bianco and Wilson, 2009). The habenula is part of a larger anti-
reward circuitry and works to inhibit transmission of the major dopaminergic regions, 
especially the ventral tegmental area (VTA) (Christoph et al., 1986; Matsumoto and 
Hikosaka, 2007). The habenula consists of medial and lateral portions and has 
recently been linked to psychoactive disorders, such as depression and anxiety, and 
inhibition of this area can help alleviate depressive symptoms in untreatable mouse 
models (Savitz et al., 2011; Lawson et al., 2016; Winter et al., 2011). In particular, the 
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lateral region of the habenula has a strong association with anti- or negative reward 
processing (Proulx et al., 2014). 
The LHb sends glutamatergic projections into the rostromedial tegmental area 
(RMTg), also referred to as the tail of the VTA (Hong et al., 2011). The RMTg works 
to inhibit transmission of the VTA’s dopaminergic population and, thus, inhibits reward 
processing and promotes avoidance learning. Interestingly, optogenetic stimulation of 
this pathway mimics this avoidance behavior (Stamatakis and Stuber, 2012). Other 
research shows that the lateral habenula region may be important with decision-
making due to the fact that it is most reactive to stimuli involved with aversive, 
contingency learning (Laurent et al., 2017). This is probably due to the fact that 
projections from the LHb to the RMTg seem to signal in a phasic fashion and are 
reactive to specific behavior and stimuli (Proulx et al., 2014). 
Alcohol and lateral habenula 
 There is little evidence of the role of the LHb in modulating binge-like ethanol 
drinking. When the LHb is stimulated at a high frequency voluntary EtOH consumption 
is reduced (Li et al., 2016). One study showed that EtOH drives aversive conditioning 
through DA1 receptor and glutamate receptor meditated activation in the LHb (Zuo et 
al., 2017). When α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
receptors and the activity of calcium-calmodulin-dependent protein kinase type 2 
(CaMKII) is inhibited depressive-like phenotypes emerge and alcohol intake is 
reduced (Li et al., 2017). Lesioning the LHb does not seem to have any effect on 
voluntary alcohol consumption (Donaire et al., 2019). Low dose EtOH excites 
projections to the VTA, RMTg, and raphe (Fu et al., 2017). During alcohol withdrawal, 
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anxiety-like phenotype seems to be driven by specific serotonin receptors and M-type 
K+ channels and activation of glycine receptors rescues anxiety and depressive 
behaviors associated with withdrawal and reduces EtOH intake (Fu et al., 2019; Li et 
al., 2019). 
Central amygdala to lateral habenula circuitry 
 There is little to no previous evidence of connection between the CeA and the 
LHb. Within our lab we have used anterograde tracing viral-mediated vectors injected 
into the CeA in order to map downstream targets from this region in two transgenic 
mouse lines that target GABAergic neurons, vgat-ires-cre, and Y1R-expressing 
neurons, NPY1R-cre. While we see expected terminals in areas in both transgenic 
models such as the BNST and VTA presented in Fig. 1.1A and Fig. 1.1B, respectively, 
we also see a projection from both mouse lines into the lateral portion of the LHb in 
Fig. 1.1C. One other group has published on this circuitry, seeing this projection with 
somatostatin neurons in the CeA to the LHb which related the dysfunction of a neuro-
feedback loop associated with depressive symptoms associated with pain (Zhou et 
al., 2019).  
Goals of the current dissertation  
 The overall goals of this current dissertation in to uncover the role of this LHb-
projecting CeA circuit in the modulation of a voluntary binge-like EtOH drinking 
model, and the role of the RMTg as a downstream target, and how an acute 
exposure to voluntary binge-like EtOH consumption modulations cellular properties, 
EtOH reactivity, and NPY responsivity within these CeA neurons projecting to the 
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LHb. The first has been achieved through the utilization of a targeted chemogenetic 
approaches in association with transgenic animal lines allowing for inhibition of the 
GABAergic and Y1R-expressing CeA projections to the LHb and a multiplexing 
chemogenetic approach that utilizes dual chemogenetic inhibition of the Y1R-
expressing CeA projection to the LHb and of the RMTg overall. The second was 
achieved by utilizing cre-dependent tags and retroviral-tags along with in vitro 
electrophysiological recordings to target CeA Y1R-expressing neurons projecting to 
the LHb. The second chapter will describe how chemogenetic inhibition of 
GABAergic LHb-projecting CeA neurons modulate binge-like EtOH and sucrose 
intake. In this experiment we bilaterally injected a cre-dependent hM4Di-coupled 
DREADD or empty vector control into the CeA of vgat-ires-cre male and female mice 
while simultaneously bilaterally cannulating the LHb for microinfusion of CNO or 
vehicle. The third chapter explored how chemogenetic inhibition of Y1R-expressing 
LHb-projecting CeA neurons modulate binge-like EtOH and sucrose intake. In a 
similar fashion as the previous experiment, we utilized bilateral injections of a cre-
dependent hM4Di-coupled DREADD or empty vector control into the CeA of npy1r-
cre male and female mice while simultaneously bilaterally cannulating the LHb for 
microinfusion of CNO or vehicle. The fourth chapter investigated the effect of a dual 
inhibition of the Y1R-expressing CeA population projecting to the LHb and of the 
RMTg overall neuronal population on the modulation of binge-like EtOH and sucrose 
intake. This was achieved by bilateral injections of a cre-dependent inhibitory KORD 
or empty vector control into the CeA of npy1r-cre male and female mice, bilaterally 
cannulating the LHb for microinfusion of SalB or vehicle, and bilateral injection of a 
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neuronal hD4Mi-coupled DREADD into the RMTg for i.p. injections of CNO or 
vehicle. Finally, the fifth chapter explored how acute exposure to voluntary binge-like 
EtOH consumption modulates cellular properties, EtOH reactivity, and NPY 
responsivity within these Y1R-expressing CeA neurons projecting to the LHb. We 
accomplished this through bilaterally injections of a cre-dependent hD4Mi-coupled 
DREADD and retroAAV tagged with enhanced green fluorescent protein (eGFP) into 
the CeA and LHb, respectively. Then we followed with exposure to one cycle of DID 
with EtOH or water and in vitro electrophysiological recording with y-tube application 
of EtOH and NPY pharmacology. Collectively, these experimental findings enhance 
our overall understanding of the neurological systems associated with non-
dependent binge-like EtOH intake and help better the understanding of this CeA 
projection to the LHb. The results could provide an important target in relation to 
possible neuro-feedback loops that are overtaken by things such as EtOH and 
perhaps provide a better understanding of how to reset the brakes of the system or 
possibly reset it overall. These results provide great information to build future 




Figure 1.1. CeA terminal staining within the LHb or both vgat-ires-cre and npy1r-
cre mice.  The left shows eGFP GABAergic terminals in vgat-ires-cre animals and the 








ASSESMENT OF CHEMOGENETIC INHIBITION ON LATERAL HABENULA-
PROJECTING GABAERGIC CENTRAL AMYGDALA NEURONS IN 
MODULATING BINGE-LIKE ETHANOL INTAKE 
Introduction 
 Excessive alcohol use impedes society with many health and economic risks 
(Esser et al., 2020). This excessive alcohol use is seen across age groups and within 
many different groups and classes of people (Waller et al., 2014; Rutledge et al., 2016; 
Esser et al., 2014). One of the most common forms of excessive drinking is binge 
drinking. This form of drinking is defined as drinking enough alcohol within a two-hour 
window to reach or exceed that of the legal limit; which is a BEC greater than 0.08% 
(80 mg/dL) (NIAAA, 2004). Binge alcohol consumption is the one of the worst forms 
of economic burden when it comes to excessive drinking, accounting for over 75% of 
the annual economic costs (Sacks et al., 2015). In order to obtain preclinical research 
on voluntary binge-like drinking the “drinking-in-the-dark”, or DID, model was created 
(Rhodes et al, 2005; Thiele et al, 2014; Holgate et al., 2017). This model has become 
a useful tool in uncovering the neuromechanisms involved with binge-like 
consumption of EtOH, especially within the CeA (Sprow and Thiele, 2012; Lowery-
Gionta et al., 2012). 
 The CeA is the major output for the entire amygdala complex and is a vast 
population of GABAergic projection and interneurons (Swanson and Petrovich, 1998). 
The CeA is well-known in its relation to EtOH (Hyytiä and Koob, 1995; Gilpin et al., 
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2011). Previous research has shown that EtOH increases GABA release from pre- 
and post-synaptic sites within the CeA (Roberto et al, 2003).  This same group has 
also found that GABA transmission is increased in a EtOH-dependent rat model 
(Roberto et al., 2004). In order to better understand behaviors regulated by the CeA, 
serving as the major output for the overall amygdala, investigating known and 
uncovering novel pathways from this region and their relation to ethanol consumption 
are essential and largely unstudied. As shown previously in figure 1.1, through the 
anterograde tracing of fluorescent protein injected into the CeA, we have found 
GABAergic terminals in the lateral portion of the LHb.  
 The LHb is a vitally conserved region of the vertebrate brain and is well-known 
for the involvement in affective disorders and depressive behavior (Bianco and Wilson, 
2009; Savitz et al., 2011; Lawson et al., 2016; Winter et al., 2011). The LHb is also 
important in avoidance and anti-reward behavior (Proulx et al., 2014). In relation to 
EtOH, high-frequency stimulation of this region reduces voluntary EtOH consumption 
(Li et al, 2016). Although this CeA→LHb circuit has been found to have an effect in 
relation to chronic pain and the depressive-like behavior associated with this pain, this 
research was completed in respect to the somatostatin (SOM) population and not the 
overall GABAergic neurons (Zhou et al., 2019). The role of this overall GABAergic 
circuit in relation to EtOH, voluntary consumption, and binge-like consumption remains 
unexplored. 
 The experiments that follow were designed to explore the role of this 
GABAergic LHb-projecting CeA population in binge-like EtOH consumption. 
Chemogenetic modulation of GABAergic CeA terminals through the use of DREADDs, 
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and site-directed designer drug infusion, allowed us to demonstrate that inhibition of 
this circuit blunts binge-like consumption of 20% EtOH. In order to determine effect 
specificity, we measured intake of 3% sucrose during inhibition of this GABAergic 
population. There was no significant change in sucrose consumption with inhibition 
this circuit. These results elucidate this novel circuit and its role in the consumption of 
EtOH while also suggesting this circuit to be of importance in possibly driving non-
dependent excessive alcohol consumption through inhibition of LHb neurons.  
Methods 
Animals 
 Male and female vgat-ires-cre mice backcrossed on a C57BL/6J strain, were 
utilized for this study. All animals were individually housed following surgical 
procedures with ad libitum access to water and Prolab® RMH 3000 (Purina labDiet®; 
St. Louis, MO). Th animal vivarium was maintained at 22˚C on a 12:12 h reverse 
light/dark cycle. All protocols were conducted under National Institute of Health 
guidelines and were approved by the University of North Carolina Institutional Animal 
Care and Use Committee. 
Surgery 
 Mice were anesthetized via an i.p. ketamine (66.7 mg/kg; Henry Schein, Dublin, 
OH) and xylazine (6.67 mg/kg; Henry Schein) cocktail. The analgesic, meloxicam, was 
administered at (0.1mL/10g) via i.p. injection before surgical procedure. A 1% 
lidocaine HCl (Hospira, Inc., Lake Forest, IL) volume of 0.1mL was subcutaneously 
applied above the skull. Mice received bilateral infusion of 0.5ul of inhibitory DREADD, 
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AAV8-hSyn-DIO-hM4d(Gi)-mcherry (6 x 1012 vg/ml), or control vector without the 
DREADD construct AAV8-hSyn-DIO-mcherry (8 x 1012), targeting the CeA (from 
bregma AP: -1.06, ML: ±2.61, DV: -4.71). During the same surgical procedure, a 
bilateral cannula unit (Plastics1, Virginia, USA) was implanted targeting the LHb (from 
bregma AP: -1.94, ML: ±0.5, DV: -2.5). Animals underwent at least 3 weeks of 
recovery and viral incubation before the beginning of behavioral procedures with ad 
libitum access to water and food.  
DREADD and cannula placement verification 
At the completion of the study, mice were overdosed with 0.1 mL i.p. 
ketamine/xylazine (6.67 mg/0.1 mL; 0.67 mg/01. mL; in 0.9% saline) and transcardially 
perfused with 0.1 M phosphate-buffered saline (PBS) followed by 4% 
paraformaldehyde in PBS (pH = 7.4) using a Masterflex L/S perfusion pump (catalogue 
#7200-12, Cole-Parmer, Vernon Hills, IL). After extraction, tissue was post-fixed in 4% 
paraformaldehyde for up to 48hr. Brains were sectioned into 40 μm slices via 
vibratome (model VT1000 S, Leica Biosystems, Buffalo Grove, IL). Tissue was placed 
in cryopreserve and stored in a −20°C freezer. 
Drinking-in-the-dark (DID) 
Detailed description of the binge-like, voluntary consumption paradigm is 
described in previous research (Thiele et al., 2014). Briefly, DID is a 4-day paradigm 
where typical mouse water bottles are replaced 3-hours into the 12-hr dark cycle with 
a modified 10 mL pipette filled with 20% (v/v) EtOH solution. After a 2-hour timeframe, 
EtOH bottles were removed and typical water bottles were returned. On test day 
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(fourth day) experimental manipulation occurred before access to EtOH solution. 
Following 2-hour access on test day, EtOH was removed and the lateral vein was 
utilized to collect approximately 30µl of tail-blood from each mouse which were then 
analyzed using the Analox Analyzer (Analox Instruments, Lunenburg, MA, USA). 
During this paradigm mice normally reach or exceed binge-level BECs as defined by 
the NIAAA, 80 mg/dl (Thiele et al., 2014). 
Experimental procedures 
Inhibition of LHb-projecting GABA-ergic CeA neurons 
 Proceeding between 3 and 4-weeks of recovery and virus transduction, animals 
were cycled through 2-consectutive DID cycles with 20% EtOH solution. Animals were 
habituated to handling on day 2 and 3 of drinking before testing and received mock 
saline injections on day 3. On test days, 30 min prior to EtOH consumption, mice were 
microinfused into bilateral cannulae targeted to the LHb with vehicle (saline+1% 
DMSO; 0.3 µl/1min infusion/hemisphere) or CNO (900 pmol/0.3 µl/1 min 
infusion/hemisphere; dosed based on our labs previous work (Rinker et al., 2016)). 
Mice were counter-balanced based on consumption levels observed during the first 3 
days of access during the DID cycle into vehicle or CNO groups to ensure equal 
average baselines between the two drug groups. During the second DID cycle, mice 
received the opposite drug treatment creating a counter-balanced Latin square design 
and allowing each animal to serve as its own control group. Following EtOH testing, 
1-week of recovery was allowed before an addition 2-weeks of DID cycle testing with 
3% sucrose solution to determine if chemogenetic manipulation of the circuit was 




For drinking studies, repeated-measures general linear models (GLM) analysis 
failed to detect a significant effect of sex or drug-order and thus both factors were 
included as covariate factors while the within-subject factors were that of drug 
treatment (CNO vs. vehicle) and between subject factors being viral vector (active 
drug vs. control) and paired t- tests (treatment; total consumption and BECs) for each 
viral condition were used. GLMs were performed in SPSS 25 (IBM Analytics, Armonk, 
New York) and paired t-test were ran through GraphPad Prism 9 (La Jolla, CA). 
Findings are presented as mean ± standard error of the mean (SEM) and considered 
significant if p < 0.05 (two-tailed). 
Results 
DREADD-driven inhibition of LHb-projecting GABA-ergic CeA neurons significantly 
blunts binge-like EtOH consumption and BECs within vgat-ires-cre mice. 
 The viral and cannula placement for these animals can be seen in Fig. 2.1, 
while the data from binge-like EtOH experiments can be seen in Fig. 2.2. In Fig. 2.2A 
and B we can see that there is a significant interaction of CNO treatment and virus 
[treatment: F(1,16)=3.159, p=0.095; treatment*sex interaction: F(1,16)=0.471, 
p=0.503; treatment*drug-order interaction: F(1,16)=0.119, p=0.773); treatment*virus 
interaction; F(1,17)=5.026, p=0.040] and performing a paired t-test, we can see that 
this significant interaction is specifically when CNO was administered to the active 
DREADD group (t(1,9)=5.938,p=0.0001) and no effect of vehicle on this group and no 
effect of CNO or vehicle on control viral vector animals (t(1,9)=0.5759, p=0.5788).  
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We can also see that there is also a significant difference in the BEC levels of 
these groups as well, with a significant effect of treatment on BEC levels seen in Fig. 
2.2C and D. There was one blood from the group that was lost in processes and thus 
is one less than the subject number in the behavioral data [treatment: F(1,15)=6.033, 
p=0.027; treatment*sex interaction: F(1,15)=0.140, p=0.714; treatment*drug-order 
interaction: F(1,15)=0.427, p=0.523; treatment*virus interaction: F(1,15)=4.226, 
p=0.058]. When we look at where this significant effect of treatment is, we can see 
that it is in the same group of active Gi/oDREADD and CNO treatment [t(1,9)=5.419, 
p=0.0004] and there is no significant effect of CNO treatment on control vector animals 
[t(1,8)=0.5904, p=0.5712].  
DREADD-driven inhibition of LHb-projecting GABA-ergic CeA neurons does not 
significantly blunt binge-like sucrose consumption within vgat-ires-cre mice. 
 Since the animals from the EtOH study are the same that were tested for 
sucrose consumption as well the same viral and cannula placements can be seen in 
Fig. 2.1. When looking at the drinking data of 3%sucrose solution in Fig. 2.3, we can 
see that there is no significant effect of treatment nor interaction of treatment with any 
factor [treatment: F(1,16)=4.107, p=0.60; treatment*drug-order interaction: 
F(1,16)=1.729, p=0.207; treatment*sex interaction: F(1,16)=0.084, p=0.776; 
treatment*virus interaction: F(1,16)=0.455, p=0.509]. There were, however, significant 
effects of the between-subject factors of sex [F(1,16)=6.983, p=0.018] and virus 
[F(1,16)=5.273, p=0.036]. These are not surprising, however, and are not in 





 These experiments were conducted to uncover the possible role of this 
GABAergic, LHb-projecting CeA circuit in binge-like EtOH consumption. Our results 
show that chemogenetic inhibition of the circuit blunts the binge-like consumption of 
20% EtOH. These results were only present in the group with the active Gi/oDREADD 
construct and not in the control viral vector group. This shows that CNO only does not 
alter EtOH binge-like consumption. We can see that same significant reduction in the 
BECs collected from these animals in the Gi/oDREADD group as well after the two-
hour EtOH drinking sessions. This inhibition of the GABAergic LHb-projecting CeA 
circuit did not lead to a significant reduction in binge-like consumption of 3% sucrose 
solution. This shows a specific effect to alcohol with manipulation of this circuit. There 
were significant main effects of sex and virus on drinking levels, though this is not 
significant to the interpretation of the experiments and manipulations. 
 It is not surprising that there are sex differences in overall drinking levels. Many 
studies have shown that, generally, females have a higher amount of consumption 
than males (Lancaster, 1995). Within this study, however, there was no interaction 
with any other factor and thus there is no difference in sex in in relation to the 
experimental manipulations of this study and is only due to the overall higher 
consumption in females. 
 The results of this study add to the knowledge of this novel circuit in regards to 
the early stages of binge-like consumption before the state of dependence. Given that 
EtOH in the CeA enhances GABA transmission at both pre- and post-synaptic sites 
(Roberto et al, 2003), it could be that this circuit is responsible for reducing alcohol 
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consumption when levels begin to elevated within this region. In this concept, EtOH 
enhances this GABA transmission from other neurons within the CeA and this inhibits 
these LHb-projecting neurons which would reduce drinking just as in our study. This 
is the concept of disinhibition, such that other inhibitory neurons inhibit other inhibitory 
neurons and thus letting the brakes off of the downstream target (Möhler and Rudolph, 
2017). In this case, this would be letting the brakes off of the LHb, which is an area 
known for driving avoidance and anti-reward behavior (Proulx et al, 2014). The LHb-
projecting CeA circuit might be a circuit that is vital for control of EtOH consumption 
and could be a key target for a mechanism by which EtOH causes a loss of control 
within feedback-loops within the brain. 
  While GABA is the main target in this study, there are other inhibitory 
molecules that are co-expressed within these neurons. One of these is NPY, the most 
abundant neuropeptide in the CNS and is predominantly within GABAergic 
interneurons (Hokfelt, 1991; Hokfelt et al., 1980). Moreover, it has been shown that 
overexpression and infusion of NPY within the CeA reduces self-administration in rat 
models and that NPY blocks the transition to EtOH dependence (Primeaux et al., 
2006; Gilpin et al., 2008; Gilpin et al., 2011). One of the main receptors for the binding 
and action of NPY is the Y1R, and it is a Gi/o-coupled receptor (Acuna-Goycolea et al., 
2005). This could be a good target as being a mechanism for this disinhibition system 
that could make this circuit protective against heavy alcohol consumption that could 
lead to worse dependence consequences. Overall, this study adds to the knowledge 
of circuitry stemming from the CeA and the novel projection to the LHb. From these 
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Figure 2.1. Cannula placement and viral spread within vgat-ires-cre mice.  A. 
LHb cannula placements within vgat-ires-cre mice. B. Representative image of viral 

















Figure 2.2. DREADD-driven inhibition of LHb-projecting CeA GABAergic 
neurons blunts binge-like EtOH consumption in vgat-ires-cre male and female 
mice. A. CNO, not vehicle, microinfused into the LHb blunted binge-like EtOH 
consumption in animals with Gi/oDREADD viral vector (n=10; male n=7 and female 
n=3), and not control (n=10; male n=6 and female n=4) B. Same data as A displayed 
as paired subjects. C. BECs are also blunted in the CNO-treated Gi/oDREADD group 
(n=10; male n=7 and female n=3) and not in the control vector (n=10; male n=5 and 
female n=4) D. Same data as C as paired subjects across treatments. *** indicates 
p<0.001 and **** indicates p<0.0001 paired t-test (two-tailed). Data collapsed across 




























































































Figure 2.3. DREADD-driven inhibition of LHb-projecting CeA GABAergic 
neurons does not blunt binge-like consumption of 3% sucrose in vgat-ires-cre 
male and female mice. A. CNO microinfusion fails to alter binge-like consumption in 
Gi/oDREADD vector group (n=10; male n=7 and female n=3) and control group (n=10; 
male n=6 and female n=4) All values indicate mean ± SEM. B. Same data as A shown 

































































ASSESMENT OF CHEMOGENETIC INHIBITION ON LATERAL HABENULA-
PROJECTING NEUROPEPTIDE Y1 RECEPTOR-EXPRESSING CENTRAL 
AMYGDALA NEURONS IN MODULATING BINGE-LIKE ETHANOL INTAKE 
 
Introduction 
 The CeA, a GABAergic population serving to as the main output center of the 
amygdala complex, houses an array of neuropeptides co-expressed in this GABAergic 
population (Swanson and Petrovich, 1998; Allen et al., 1989; Roberto et al., 2012). 
One of these peptides is neuropeptide Y (NPY), one of the most abundant peptides in 
the CNS and predominantly expressing within GABAergic interneurons (Hokfelt, 
1991). It is well-known to the anxiolytic counterpart to the anxiogenic neuropeptide, 
corticotropin releasing factor (CRF), and implements these anxiolytic effects through 
binding-interaction with the Y1 receptor (Y1R) (Valdez and Koob, 2004; Kash and 
Winder, 2006; Heilig et al, 1989). 
 NPY has had many implications in alcohol studies as being a neuroprotective 
mechanism against EtOH consumption by reducing drinking and reducing GABAergic 
transmission (Thiele et al 1998; Thiele et al 2000; Gilpin et al., 2011). This reduction 
of EtOH intake by NPY results from signaling in brain regions that regulate emotions 
and stress, but has an opposite effect in hypothalamic areas linked to feeding behavior 
(Ehlers et al, 1998; Hayes et al, 2005; Mirsa and Pandey, 2006). Given this 
information, it is not surprising that NPY effects within the CeA match with the trend 
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of decreasing responding and consumption of EtOH (Gilpin et al., 2008; Primeaux et 
al., 2006; Sparrow et al 2012). NPY has also been seen to oppose the effects of EtOH 
and block the transition to dependence (Gilpin et al, 2011).      
Our findings reported in Chapter 2 show a role for the CeA→LHb GABAergic 
circuit in avoidance behavior and suggests that this pathway may be involved in 
driving drinking due to the fact that our inhibition of it reduces consumption of EtOH. 
With our other previous finding shown in Figure 1.1, it seems that there is a subset of 
these projection neurons that NPY-releasing interneurons within the CeA interact with 
to cause this reduction in EtOH consumption and may be driving the effect seen in the 
studies conducted in Chapter 1. 
 Therefore, our goal of Chapter 3 was to evaluate a NPY1R-expressing subset 
of the GABAergic LHb-projecting CeA neurons in modulating voluntary binge-like 
consumption of EtOH utilizing the DID paradigm. To this end, we infused cre-
dependent Gi/oDREADD or control vector virus into the CeA of npy1r-cre mice while 
cannulating the lateral portion of the LHb in order to specifically modulate this circuit 
through the microinfusion of the designer drug, clozapine-N-oxide (CNO), onto the 
CeA terminals in the LHb. We found that inhibitory chemogenetic manipulation of this 
Y1R-expressing circuit significantly reduced binge-like consumption of EtOH. 
Furthermore, we did not see this same blunting of 3% sucrose consumption. These 
findings implicate that this manipulation is specific to modulating EtOH consumption 
and not that of other reinforcing substances and suggests that, compared to our 
findings from Chapter 2, this specific Y1R-expressing population to the LHb may differ 
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in the role of voluntary EtOH consumption compared to the overall GABAergic LHb 
projection.   
Methods 
Animals 
 Male and female npy1r-cre mice, backcrossed on a C57BL/6J strain, were 
obtained from Dr. Richard Palmiter at the University of Washington and utilized for this 
study. All animals were individually housed following surgical procedures with ad 
libitum access to water and Prolab® RMH 3000 (Purina labDiet®; St. Louis, MO). Th 
animal vivarium was maintained at 22˚C on a 12:12 h reverse light/dark cycle. All 
protocols were conducted under National Institute of Health guidelines and were 
approved by the University of North Carolina Institutional Animal Care and Use 
Committee. 
Surgical procedures 
 Mice were anesthetized via an i.p. ketamine (66.7 mg/kg; Henry Schein, Dublin, 
OH) and xylazine (6.67 mg/kg; Henry Schein) cocktail. The analgesic, meloxicam, was 
administered at (0.1mL/10g) via i.p. injection before surgical procedure. A 1% 
lidocaine HCl (Hospira, Inc., Lake Forest, IL) volume of 0.1mL was subcutaneously 
applied above the skull. Mice received bilateral infusion of 0.5ul of inhibitory DREADD, 
AAV8-hSyn-DIO-hM4d(Gi)-mcherry (6 x 1012 vg/ml), or control vector without the 
DREADD construct, AAV8-hSyn-DIO-mcherry (8 x 1012), targeting the CeA (from 
bregma AP: -1.06, ML: ±2.61, DV: -4.71). During the same surgical procedure, a 
bilateral cannula unit (Plastics1, Virginia, USA) was implanted targeting the LHb (from 
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bregma AP: -1.94, ML: ±0.5, DV: -2.5). Animals underwent at least 3 weeks of 
recovery and viral incubation before the beginning of behavioral procedures with ad 
libitum access to water and food.  
DREADD and cannula placement verification 
 At the completion of the study, mice were overdosed with 0.1 mL i.p. 
ketamine/xylazine (6.67 mg/0.1 mL; 0.67 mg/01. mL; in 0.9% saline) and transcardially 
perfused with 0.1 M phosphate-buffered saline (PBS) followed by 4% 
paraformaldehyde in PBS (pH = 7.4) using a Masterflex L/S perfusion pump (catalogue 
#7200-12, Cole-Parmer, Vernon Hills, IL). After extraction, tissue was post-fixed in 4% 
paraformaldehyde for up to 48hr. Brains were sectioned into 40 μm slices via 
vibratome (model VT1000 S, Leica Biosystems, Buffalo Grove, IL). Tissue was placed 
in cryopreserve and stored in a −20°C freezer. 
Immunohistochemistry 
 A subset of extra tissue from test animals was taken for processing of CRF 
antibody reactivity as previously described (Companion and Thiele, 2018). Briefly, 
primary Anti-CRF Rabbit antibody (Abcam Inc., Cambridge, MA; ab8901) was used 
at a concentration of 1:250 mixed into blocking solution for 48 to 72 hours (Garcia-
Moreno et al., 2010; Cuevas Guaman et al., 2014). Tissue was then processed with 
secondary fluorescent antibody Donkey Anti-Rabbit Alexa Flour 488 (Abcam Inc., 
Cambridge, MA). Finally, tissue was mounted with Vectashield Hard Set Medium 
containing DAPI (Vector Laboratories, Burlingame, CA) and imaged using a Zeiss 




Detailed description of the binge-like, voluntary consumption paradigm is 
described in previous research (Thiele et al., 2014). Briefly, DID is a 4-day paradigm 
where typical mouse water bottles are replaced 3-hours into the 12-hr dark cycle with 
a modified 10 mL pipette filled with 20% (v/v) EtOH solution. After a 2-hour timeframe, 
EtOH bottles are removed and typical water bottles are returned. On test day (fourth 
day) experimental manipulation occur before access to EtOH solution. Following 2-
hour access on test day, EtOH is removed and the lateral vein was utilized to collect 
approximately 30µl of tail-blood from each mouse which were then analyzed using the 
Analox Analyzer (Analox Instruments, Lunenburg, MA, USA). During this paradigm 
mice normally reach or exceed binge-level BECs as defined by the NIAAA, 80 mg/dl 
(Thiele et al., 2014). 
Experimental procedures 
Inhibition of LHb-projecting Y1R-expressing CeA neurons 
Proceeding between 3 and 4-weeks of recovery and virus transduction, animals 
were cycled through 2-consectutive DID cycles with 20% EtOH solution. Mice were 
habituated to handling on day 2 and 3 before testing and received a mock infusion of 
saline on day 2. On test days, 30 min prior to EtOH consumption, mice were 
microinfused into bilateral cannulae targeted to the LHb with vehicle (saline+1% 
DMSO; 0.3 µl/1min infusion/hemisphere) or CNO (900 pmol/0.3 µl/1 min 
infusion/hemisphere; dosed based on our labs previous work (Rinker et al., 2016)). 
Mice were counter-balanced based on consumption levels observed during the first 3 
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days of access during the DID cycle into vehicle or CNO groups to ensure equal 
average baselines between the two drug groups. During the second DID cycle, mice 
received the opposite drug treatment creating a counter-balanced Latin square design 
and allowing each animal to serve as its own control group. Following EtOH testing, 
1-week of recovery was allowed before an addition 2-weeks of DID cycle testing with 
3% sucrose solution to determine if chemogenetic manipulation of the circuit was 
specific to EtOH consumption. 
Data Analysis 
For drinking studies, repeated-measures general linear models (GLM) analysis 
failed to detect a significant effect drug-order and, thus, was included as covariate 
factor while the within-subject factors were that of drug treatment (CNO vs. vehicle) 
and between subject factors being viral vector (active drug vs. control) and sex. Paired 
t- tests (treatment; total consumption and BECs) for each viral condition were used. 
GLMs were performed in SPSS 25 (IBM Analytics, Armonk, New York) and paired t-
test were ran through GraphPad Prism 9 (La Jolla, CA). Findings are presented as 









DREADD-driven inhibition of LHb-projecting Y1R-expressing CeA neurons 
significantly blunts binge-like EtOH consumption but not BECs within NPY1R-cre 
mice. 
 Viral spread and cannula placement can be seen for NPY1R-cre animals in Fig. 
3.1A-C. Binge-like consumption of 20% EtOH is represented in Fig. 3.2. In Fig. 3.2A 
and B, significant interaction of treatment and virus on intake can be seen [treatment: 
F(1,13)=6.722, p=0.022; treatment*drug-order: F(1,13)=0.481, p=0.50; 
treatment*virus: F(1,13)=5.662, p=0.033; treatment*sex: F(1,13)=0.000, p=0.995; 
treatment*virus*sex: F(1,13)=0.899, p=0.360]. There is also a significant effect of sex 
[F(1,13)=17.992, p<0.001]. The general knowledge this provides is that females drink 
more than male in general.  
 There were no differences in BEC levels, seen in Fig.3.2C and D for this study 
aswe did not observe significant effect or interaction of treatment or virus [treatment: 
F(1,13)=1.742, p=0.210; treatment*drug-order: F(1,13)=0.004, p=0.953; 
treatment*virus: F(1,13)=2.168, p=0.165; treatment*sex: F(1,13)=2.165, p=0.165; 
treatment*virus*sex: F(1,13)=0.053, p=0.0.821]. In between-subjects effects there 
was a significant effect of sex, which is due to the higher drinking within female 
subjects, and no other main effects or interactions [sex: F(1,13), p<0.001]. 
DREADD-driven inhibition of LHb-projecting Y1R-expressing CeA neurons fails to 
blunt binge-like sucrose consumption within NPY1R-cre mice. 
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 There was no significant effect of treatment, nor any treatment interaction on 
binge-like consumption of 3% sucrose shown in Fig. 3.3A and 3.3B [treatment: 
F(1,13)=1.262, p=0.282; treatment*drug-order: F(1,13)=0.323, p=0.580; 
treatment*virus: F(1,13)=1.519, p=0.240; treatment*sex: F(1,13)=0.333, p=0.574; 
treatment*virus*sex: F(1,13)=2.299, p=0.153]. There is a significant main effect of the 
between-subject factor of sex [F(1,13)=11.208, p=0.005]. Again, informing that 
females across groups drink more than males.  
Co-localization of CRF anti-body and cre-dependent virus targeted to npy1r-cre mice 
show another possible co-releasing mechanism of this circuit in Fig. 3.4 
In Figure 3.4 we see that mCherry (red) labeling of the Y1R+ neurons within the CeA 
overlaps with the AlexaFlour488 (green) which is tagged to CRF antibody binding to 
CRF protein. This overlap produces a yellow coloring and it referenced with an arrow 
in the figure. This shows that CRF and Y1R coexist is a subpopulation of neurons in 
the CeA. 
Discussion 
 The studies in this chapter were constructed to uncover the role of the 
subpopulation of GABAergic neurons expressing the Y1R in the CeA and projecting 
to the LHb in modulating binge-like EtOH consumption. Our results show a significant 
reduction in binge-like consumption of EtOH. We did not see significant differences in 
BEC levels; however, Fig.3.2C and D show that the mean did dip below binge levels 
of consumption. We did not see a significant reduction in 3% sucrose consumption. 
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Our IHC efforts also show that a subpopulation of these Y1R-expressing neurons are 
co-expressing CRF. 
 While we did not see an interaction effect of sex with treatment there are known 
to be sex differences in the NPY system in general. In a recent review, a meta-analysis 
of NPY and effects in animal models shows drastic differences in the NPY system and 
receptor expression between males and females (Eva et al., 2020). This sheds a large 
amount of light on the results we see from these studies with manipulation of neurons 
expressing Y1R. In particular, a study looking at viral-mediated overexpression of NPY 
within the CeA specifically had drastic effects on reducing stress-induced obesity and 
energy expenditure only within male mice, but, not within females (Ip et al., 2019). 
Another study of overall amygdalar overexpression of NPY showed a reduction in 
alcohol consumption as well as anxiety and once again these effects are only apparent 
in male mice (Thorsell et al., 2007). This is important information for future studies 
looking into the NPY system and a powering for possible sex differences. Our results 
seem to be just simply due to the fact that females tend to drink more than males, 
which may be an important factor after a long history of drinking.  
 With our current statistical standings, it would seem that the Y1R system could 
be a brake mechanism for the circuit under investigation and fall along the lines as 
acting as a disinhibitor. With the Y1R being a Gi-coupled receptor, we seem to be 
mimicking the actions that this peptide would have on these cells with the 
chemogenetic Gi/oDREADD receptor. Knowing previous research done within the 
extended amygdala, NPY is responsible for the inhibition of CRF neurons, which are 
known to cause a stress response and increase in drinking, thus adding protection 
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against EtOH consumption (Pleil et al, 2015; Valdez and Koob, 2004; Kash and 
Winder, 2006). Our IHC within this study indicates that there are a population of these 
Y1R-expressing neurons that also co-express CRF (Fig. 3.4). This could indicate that 
in a similar fashion to the extended amygdala, some of these projection neurons could 
be CRF+ and work to enable drinking, while the Y1R are responsible for controlling 
this circuit. 
 Another interesting area to investigate would be to see if the downstream 
targets of this circuit also could modulate possible sex differences as far as reaction 
to manipulation and behavioral output. Given the anxiety effects that are seen from 
the NPY system, mostly anxiolytic, we cannot rule out a reduction in anxiety-like 
behavior could lead to the change in consumptive behavior as well (Heilig et al, 1989; 
Heilig et al 1992; Pellow et al 1985, File 1980, Broqua et al 1995; Pich et al, 1993). 
These current studies add to the knowledge of the novel LHb-projecting CeA circuit 





Figure 3.1. Cannula placement and viral spread within npy1r-cre mice. A. LHb 
cannula placements within npy1r-cre mice. B. Representative image of viral 



















Figure 3.2. DREADD-driven inhibition of LHb-projecting CeA Y1R+ neurons 
blunts binge-like EtOH consumption in npy1r-cre mice. A. CNO, not vehicle, 
microinfused into the LHb blunted binge-like EtOH consumption in animals with 
Gi/oDREADD viral vector (n=9; male n=5 and female n=4), and not control (n=9; male 
n=5 and female n=4) All values indicate mean ± SEM B. Same data as A displayed 
as paired subjects. C. BECs are not significantly altered in the CNO-treated 
Gi/oDREADD group (n=9; male n=5 and female n=4) nor the control vector (n=9; male 
n=5 and female n=4) D. Same data as C as paired subjects across treatments. ** 


























































































Figure 3.3. DREADD-driven inhibition of LHb-projecting CeA Y1R+ neurons 
does not blunt binge-like consumption of 3% sucrose in vgat-ires-cre male and 
female mice. A. CNO microinfusion fails to alter binge-like consumption in 
Gi/oDREADD vector group (n=9; male n=5 and female n=4) and control group (n=9; 
male n=5 and female n=4) All values indicate mean ± SEM. B. Same data as A shown 
































































Figure 3.4. Co-localization of CRF anti-body and cre-dependent virus targeted 
to npy1r-cre mice. Cre-dependent mCherry-tagged virus, injected into the CeA of 
npy1r-cre animals has a subpopulation that co-localizes with the CRF antibody tagged 








A MULTIPLEX CHEMOGENETIC APPROACH: 
SIMULTANEOUS INHIBITION OF LATERAL HABENULA-ROJECTING, 
NEUROPEPTIDE Y1 RECEPTOR-EXPRESSING CENTRAL AMYGDALA 
NEURONS AND ROSTROMEDIAL TEGMENTAL AREA NEURONS IN 
MODULATING BINGE-LIKE ETHANOL INTAKE  
 
Introduction 
 We have shown in Chapter 2 that inhibiting GABAergic neurons in the CeA 
projecting to the LHb blunts binge consumption of EtOH, but failed to cause a 
reduction in sucrose consumption. We then examined the role of a subpopulation of 
these GABAergic neurons expressing the Y1R and found that inhibiting these specific 
neurons in the circuit blunted binge-like EtOH consumption, but not of sucrose. It 
would seem that once narrowing down that population of projection neurons that we 
have found a population that could play an important role in the drive of binge-like 
alcohol consumption. Our next goal was to figure out if there is a potential downstream 
target of the LHb that may be driving this blunting of EtOH consumption. 
 The LHb has been known to be involved with an array of affective disorders 
(Savitz et al., 2011; Lawson et al., 2016; Winter et al., 2011). The lateral region of the 
LHb, that has been shown to be innervated by the CeA in Chapter 1, and plays a very 
important role in the processing of anti-reward (Proulx et al., 2014). This information, 
along with the fact that the LHb circuitry is known to inhibit that transmission of 
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dopamine (DA) and major dopaminergic areas (Christoph et al, 1986; Matsumoto and 
Hikosaka, 2007), suggests that the LHb sends its glutamatergic projections to some 
populations that are known to inhibit the DA population in the VTA. One brain region 
that is known to perform this task is the RMTg. The RMTg, predominantly GABAergic, 
works to inhibit DA neurons in the VTA and thus driving anti-reward. The LHb sends 
strong projections to the region and stimulation of this particular pathway mimics 
avoidance behavior in animal models (Stamatakis and Studer, 2012). 
 In relation to alcohol, low doses of alcohol have been shown to excite 
projections stemming from the LHb and, one of the most prominent projections, being 
that to the RMTg (Fu et al., 2017). This provides a very suitable target that could be 
the downstream target of the LHb, creating a CeA → LHb → RMTg circuit, that is 
responsible for this reduction in drinking that is seen by inhibiting the GABAergic 
projections to glutamatergic LHb projections to the RMTg. An important task would be 
finding a method that would allow for the simultaneous silencing of this Y1R-
expressing LHb-projecting CeA population and the possible downstream target, the 
RMTg to see if we can reverse the blunting of binge-like consumption seen in the two 
previous chapters. In order to accomplish this, we used an inhibitory Gi-coupled 
DREADD on a neuronal-directed promoter to silence the RMTg region. 
Simultaneously we utilized a second chemogenetic cre-dependent inhibitory virus 
called KORD, which responds to the designer drug salvinorin B (SalB), in the CeA and 
cannulation of the LHb to target the same previous circuit manipulated in Chapter 3 






Male and female npy1r-cre mice, backcrossed to a C57BL/6J strain, were 
utilized for this study. All animals were individually housed following surgical 
procedures with ad libitum access to water and Prolab® RMH 3000 (Purina labDiet®; 
St. Louis, MO). The animal vivarium was maintained at 22˚C on a 12:12 h reverse 
light/dark cycle. All protocols were conducted under National Institute of Health 
guidelines and were approved by the University of North Carolina Institutional Animal 
Care and Use Committee. 
Surgical procedures 
 Mice were anesthetized via an i.p. ketamine (66.7 mg/kg; Henry Schein, Dublin, 
OH) and xylazine (6.67 mg/kg; Henry Schein) cocktail. The analgesic, meloxicam 
(source), was administered at (dose) via i.p. injection before surgical procedure. A 1% 
lidocaine HCl (Hospira, Inc., Lake Forest, IL) volume of 0.1mL was subcutaneously 
applied above the skull. Mice received bilateral infusion of 0.5ul/side of the cre-
dependent KORD inhibitory DREADD viral-construct, AAV8-hSyn-dF-HA-KORD-ires-
mCitrine (2.1 x 1013 vg/ml), or control vector, AAV8-hSyn-DIO-mCherry (2.3 x 1013 
vg/ml) into the CeA (from bregma AP: -1.06, ML: ±2.61, DV: -4.71). Mice also received 
a 0.2ul/side bilateral infusion of inhibitory DREADD, AAV8-hSyn-hM4d(Gi)-mcherry 
(2.2 x 1013 vg/ml), or control vector without the DREADD construct, AAV8-hSyn-EGFP 
(3x 1013 vg/ml), targeting the RMTg (from bregma AP: -3.9, ML: ±0.35, DV: -4.4). 
During the same surgical procedure, a bilateral cannula unit (Plastics1, Virginia, USA) 
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was implanted targeting the LHb (from bregma AP: -1.94, ML: ±0.5, DV: -2.5). Animals 
underwent at least 3 weeks of recovery and viral incubation before the beginning of 
behavioral procedures with ad libitum access to water and food. 
DREADD and cannula placement and verification 
At the completion of the study, mice were overdosed with 0.1 mL i.p. 
ketamine/xylazine (6.67 mg/0.1 mL; 0.67 mg/01. mL; in 0.9% saline) and transcardially 
perfused with 0.1 M phosphate-buffered saline (PBS) followed by 4% 
paraformaldehyde in PBS (pH = 7.4) using a Masterflex L/S perfusion pump (catalogue 
#7200-12, Cole-Parmer, Vernon Hills, IL). After extraction, tissue is post-fixed in 4% 
paraformaldehyde for up to 48hr. Brains were sectioned into 40 μm slices via 
vibratome (model VT1000 S, Leica Biosystems, Buffalo Grove, IL). Tissue was placed 
in cryopreserve and stored in a −20°C freezer. 
Drinking-in-the-dark (DID) 
Detailed description of the binge-like, voluntary consumption paradigm is described in 
previous research (Thiele et al., 2014). Briefly, DID is a 4-day paradigm where typical 
mouse water bottles are replaced 3-hours into the 12-hr dark cycle with a modified 10 
mL pipette filled with 20% (v/v) EtOH solution. After a 2-hour timeframe, EtOH bottles 
are removed and typical water bottles are returned. On test day (fourth day) 
experimental manipulation occur before access to EtOH solution. Following 2-hour 
access on test day, EtOH is removed and the lateral vein was utilized to collect 
approximately 30µl of tail-blood from each mouse which were then analyzed using the 
Analox Analyzer (Analox Instruments, Lunenburg, MA, USA). During this paradigm 
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mice normally reach or exceed binge-level BECs as defined by the NIAAA, 80 mg/dl 
(Thiele et al., 2014). 
Experimental procedures 
Simultaneous inhibition of LHb-projecting Y1R-expressing CeA neurons and RMTg 
neurons 
Proceeding between 3 and 4-weeks of recovery and virus transduction, animals 
were cycled through 2-consectutive DID cycles with 20% EtOH solution. Animals were 
habituated to i.p. injections and microinjector “mock” infusions with saline on day two 
of drinking. On test days, 30 min prior to EtOH consumption, vehicle (saline+DMSO) 
or 3.0 mg/kg clozapine-N-oxide (CNO; in 0.5% DMSO+saline solution, injected at 5.0 
ml/kg) was administered i.p. 30 to 40-min prior to ethanol access on test days and 
after 20 min mice were then microinfused into bilateral cannulae targeted to the LHb 
with vehicle (saline+1% DMSO; 0.3 µl/1min infusion/hemisphere) or 55mM SalB (0.3 
µl/1 min infusion/hemisphere). Mice were counter-balanced based on consumption 
levels observed during the first 3 days of access during the DID cycle into vehicle or 
KORD/CNO groups to ensure equal average baselines between the two drug groups. 
During the second DID cycle, mice received the opposite drug treatment creating a 
counter-balanced Latin square design and allowing each animal to serve as its own 
control group. Following EtOH testing, 1-week of recovery was allowed before an 
addition 2-weeks of DID cycle testing with 3% sucrose solution to determine if 




For drinking studies, repeated-measures general linear model (GLM) analysis 
was utilized with intake being the between-subjects factor, the within-subject factors 
were that of drug treatment and between subject factors being viral vector (Gi/Kord 
vs. Gi/control vs. control/KORD vs. control/control) and sex (male vs. female) with 
drug order (CNO-first vs. Veh-first) included as a covariate. GLMs were performed in 
SPSS 25 (IBM Analytics, Armonk, New York) and paired t-test were ran through 
GraphPad Prism 9 (La Jolla, CA). Findings are presented as mean ± standard error 
of the mean (SEM) and considered significant if p < 0.05 (two-tailed). 
RESULTS 
Simultaneous inhibition of Y1R-expressing CeA→LHb circuit and RMTg neurons does 
not blunt binge-like EtOH consumption. No effect of any group on binge-like EtOH 
consumption. 
 Dual viral placements and cannula placements can be seen in Fig. 4.1A-E. 
Overall, there does not seem to be any effect of treatment or interaction with any other 
variable [treatment: F(1,28)=0.436, p=0.514; treatment*drug order: F(1, 28)=2.088, 
p=0.160; treatment*virus: F(3,28)=0.094, p=0.963; treatment*sex: F(1,28)=0.043, 
p=0.836; treatment*virus*sex: F(3,28)=0.355, p=0.786] but there does seem to be a 
main effect of sex [F(1,28)=6.844, p=0.014]. There were no other main effects 
observed [drug order: F(1,28)=0.415, p=0.525; virus: F(3,28)=0.288, p=0.833; 




 There was not significant interaction and no main effects seen in the BECs of 
these animals Fig.4.2C and D [treatment: F(1,31)=0.003, p=0.960; treatment*sex: 
F(1,31)=0.061, p=0.807; treatment*drug order: F(1,31)=1.111, p=0.300; 
treatment*virus: F(3,31)=1.631, p=0.202; sex: F(1,31)=35.226, p=0.198; drug order: 
F(1,31)=1.730, p=0.353; virus: F(3,31)=0.271, p=0.846] 
Simultaneous inhibition of Y1R-expressing CeA→LHb circuit and RMTg neurons does 
not blunt binge-like sucrose consumption. 
 The results for sucrose consumption, seen in Fig. 4.3A and B, have a similar 
outcome as the EtOH consumption. There does not seem to be an effect of treatment 
nor any interaction [treatment: F(1,24)=0.124, p=0.728; treatment*drug order: 
F(1,24)=0.335, p=0.568; treatment*virus: F(3,24)=2.015, p=0.139; treatment*sex: 
F(1,24)=0.010, p=0.923; treatment*virus*sex: F(3,24)=0.525, p=0.669]. There is a 
between-subject interaction of virus and sex [F(224)=4.151, p=0.017]. There is also a 
between-subjects main effect of sex [F(1,24)=10.230, p=0.004] and not effects of 
other variables [drug order: F(1,24)=2.812, p=0.107; virus: F(3,24)=0.807, p=0.502]. 
Since treatment is not in this interaction, our manipulations of drug or vehicle did not 
play a part in these effects. 
Discussion 
 Overall, the results from above show that there are no significant effects of 
multiple manipulation, within any of our viral groups, in regards to the consumption of 
EtOH nor sucrose. There are many factors that contribute to such results and most 
focus around that fact that there does seem to be a vast difference between males 
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and females during this paradigm and the current study was not powered in 
anticipation for such sex-driven effects. When looking at the data, it does seem that 
males might show great influence of this circuitry manipulation (data not shown) but 
variation in results is too great. 
 One of the biggest differences between this study and the previous studies in 
Chapters 2 and 3 is that the virus used to inhibit the CeA→LHb Y1R-expressing circuit 
is a different chemogenetic inhibitor, KORD, instead of the previous Gi/oDREADD 
construct. The main reason for this difference is due to the fact that commercial 
availability did not provide a neuronal based KORD construct to inject into the RMTg 
in order to keep the original cre-dependent Gi/oDREADD in the CeA. The reason why 
this could be an issue is that the kinetics of the designer drug, SalB. SalB is a short-
lasting drug when infused into the CNS, being about 10 to 15 minutes; however, there 
is thought that it does cause a greater inhibition than the original Gi-coupled DREADD 
construct (Vardy et al., 2015). Through this same review it has been noted that SalB 
is a very selective drug specifically for the KORD construct with limited off target 
effects; however, given the already high number of microinfusions performed, we 
ourselves did not perform basic locomotor experimentation to see if effects that could 
arise are due to movement or anxiety-like behavior.  
 To our knowledge, this is the first attempt at such a circuitry manipulation within 
this paradigm and requires more exploration in order to understand that full effects of 
such a task. It is possible that SalB may have been effective within an hour-long test 
paradigm if taken into account needing an increased sample size due to the obvious 
sex differences that are seen within this study. There is also the possibility that the 
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high variability could be a product of going through a stressful experience before 
testing period. Animals in this study had to receive both a microinfusion into the CeA 
and an i.p. injection prior to drinking. This could have an influence on the behavior 
observed as it is well-known that different forms of stress and timeframe between can 
have a wide-variety of influence on drinking behavior (Becker et al., 2011). 
 A reason for the sex differences observed in this study is due to the fact that it 
is not uncommon for female mice to drink substantially more than their male 
counterparts (Satta et al., 2017; Li et al., 2019) This is a fairly common occurrence in 
most binge-like consumption experiments and does not have any relation to the 
current treatment variables within the experiment. To conclude, the current study does 
contribute to the development of multiplex procedures and is a start to the 





Figure 4.1. Cannula placement and viral spread within npy1r-cre mice. A. LHb 
cannula placements within npy1r-cre mice. B. Representative image of viral 
expression in the CeA. C. Representative image of viral spread in the RMTg. D. 
Placement maps showing approximate KORD viral spread in the CeA E. Placement 






















Figure 4.2 Simultaneous inhibition of RMTg and LHb-projecting, Y1R-
expressing CeA neurons does not blunt binge-like consumption of EtOH. 
Chemogenetic manipulation has no effect across all viral groups seen in A. KORD/Gi 
group (n=10; male n=5, female n=5), KORD/control(n=10; male n=5, female n=5), 
control/Gi(n=8; male n=4, female n=4), control/control viral group(n=9; male n=4, 
female n=5) B. This same data from A shown in a paired fashion. C. There are not 

































































































































































































Figure 4.3 Simultaneous inhibition of RMTg and LHb-projecting, Y1R-
expressing CeA neurons does not blunt binge-like consumption of sucrose. 
Chemogenetic manipulation has no effect across all viral groups seen in A. KORD/Gi 
group (n=10; male n=5, female n=5), KORD/control(n=10; male n=5, female n=5), 
control/Gi(n=8; male n=4, female n=4), control/control viral group(n=9; male n=4, 



















































































































ELECTROPHSYIOLOGICAL EXAMINATION OF LATERAL HABENULA-
PROJECTING, NEUROPEPTIDE-Y1 RECEPTOR-EXPRESSING NEURONS IN 
THE CENTRAL AMYGDALA 
Introduction 
 In Chapter 2 and 3, we examined the role of CeA GABAergic and Y1R-
expressing, LHb-projecting neurons and discovered that inhibiting both of these 
projections significantly blunts the binge-like consumption of EtOH in the DID 
paradigm. This potentially shows that this circuitry could act as a braking system for 
EtOH consumption by driving an anti-reward type of reaction.  
 Previous research has shown that EtOH enhances pre- and post-synaptic 
GABAergic transmission within the CeA and that dependent rats have an increase in 
GABA release in the CeA (Roberto et al., 2003; Roberto et al., 2004). It has also 
been shown that overexpression of NPY in the CeA reduces self-administration of 
EtOH in rats (Primeaux et al., 2006). There is also research showing that NPY 
actions oppose the effects of EtOH (Gilpin et al., 2011). Further, a history of binge-
like EtOH exposure reduces NPY protein expression within the CeA (Sparrow et al., 
2012). These previous findings indicate that acute EtOH and EtOH dependence-
associated changes in GABAergic cellular function and that mechanisms involved 
with NPY transmission are affected after a history of binge-like EtOH consumption. 
One area that has remained unstudied is what a brief exposure to the DID paradigm 
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might have on neurons within the CeA and, in our particular interest, how cells that 
project to the LHb and are known to express Y1R are specifically impacted. 
 In the current chapter, our goal was to uncover the possible differences in 
reactivity of these cells after a brief exposure to the DID paradigm using 
electrophysiological recordings of cell firing rate and baseline IPSCs followed by 
exposure to EtOH and NPY. We used male and female mice from the same npy1r-
cre transgenic line used in Chapters 3 and 4.  We had predicted that EtOH exposure 
would increase activity of these neurons and increase responsivity to acute EtOH 
exposure. We also predicted that the cells may show an enhanced response to NPY 
since EtOH is known to decrease NPY in the CeA and thus, our prediction would be 
that Y1R expression would increase after a brief alcohol exposure due to a reduced 
NPY tone. Our findings show no significant differences in IPSC characteristics in 
relation to baseline measures or in change from baseline measures during 44mM 
EtOH exposure. Our cell-attached firing and NPY portions of the experiment remain 
too underpowered in order to confidently examine statistical differences, if any exist, 
between groups.    
Methods 
Animals 
 Male and female npy1r-cre mice, backcrossed on a C57BL/6J strain, were 
utilized for this study. All animals were individually housed following surgical 
procedures with ad libitum access to water and Prolab® RMH 3000 (Purina 
labDiet®; St. Louis, MO). The animal vivarium was maintained at 22˚C on a 12:12 h 
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reverse light/dark cycle. All protocols were conducted under National Institute of 
Health guidelines and were approved by the University of North Carolina Institutional 
Animal Care and Use Committee. 
Surgical procedures  
 Mice were anesthetized via an i.p. ketamine (66.7 mg/kg; Henry Schein, 
Dublin, OH) and xylazine (6.67 mg/kg; Henry Schein) cocktail. The analgesic, 
meloxicam, was administered at (0.1mL/10g) via i.p. injection before surgical 
procedure. A 1% lidocaine HCl (Hospira, Inc., Lake Forest, IL) volume of 0.1mL was 
subcutaneously applied above the skull. Mice received bilateral infusion of 0.5ul of 
inhibitory DREADD, AAV8-hSyn-DIO-hM4d(Gi)-mcherry (6 x 1012 vg/ml) targeting 
the CeA (from bregma AP: -1.06, ML: ± 2.61, DV: -4.71) and 0.2ul bilateral retroAAV 
viral construct infusion targeting the LHb (from bregma AP: -1.94, ML: ±0.5, DV: -
2.5). Animals underwent at least 3 weeks of recovery and viral incubation before the 
beginning of behavioral procedures with ad libitum access to water and food.  
Drinking-in-the-dark (DID) 
Detailed description of the binge-like, voluntary consumption paradigm is 
described previously (Thiele et al., 2014). Briefly, DID is a 4-day paradigm where 
typical mouse water bottles are replaced 3-hours into the 12-hr dark cycle with a 
modified 10 mL pipette filled with 20% (v/v) EtOH solution. After a 2-hour timeframe, 
EtOH bottles are removed and typical water bottles are returned. On the fourth day 





Slice preparation was completed following previously-described methods (Herman 
and Roberto, 2016). In brief, slices were perfused in an oxygenated artificial 
cerebrospinal fluid (aCSF) solution containing the following (in mM): NaCl 120; KCL 
2.5; EGTA 5; CaCl2 2.0 MgCl2 1.0; NaH2PO4 1.2; NaHCO3 26; Glucose 1.75; 
HEPES 5. Whole cell voltage- and current-clamp recordings, made with a 
Multiclamp 700B amplifier and stored on a PC using pClamp 10, were made in CeA 
neurons that contained Cre labeling a NPY1R+ phenotype and that are identified as 
projecting to the LHb with retro AAV labeling. Synaptic transmission was measured 
by spontaneous inhibitory postsynaptic currents (sIPSCs) recorded in the presence 
of glutamate and GABAB receptor antagonists (CNQX, 10 µM; APV-5, 30 µM; 
CGP55845A, 1 µM), to isolate GABAA receptor currents. Patch pipettes (5-7 MΏ) 
were filled with an intracellular solution containing (in mM): potassium chloride (KCl) 
145; EGTA 5; MgCl2 5; HEPES 10; Na-ATP 2; Na-GTP 0.2 (for voltage-clamp 
recordings of sIPSCs). Excitability was measured by cell-attached recordings of 
spontaneous firing activity and current clamp recordings for rheobase and response 
to injected current steps. Neurons were then introduced to 44mM EtOH y-tube 
application and IPSCs were assessed. A washout followed and then a subset of 







Frequency, amplitude and decay of IPSCSs were analyzed using MiniAnalysis 
Synaptosoft software. Responses will be quantified as the difference between 
baseline currents and currents under experimental conditions. Events were analyzed 
for significance using a one-sample t test and compared using a two-tailed t test for 
independent samples. Findings are presented as mean ± standard error of the mean 
(SEM) and considered significant if p < 0.05 (two-tailed). 
Results 
A brief exposure to binge-like EtOH drinking does not significantly alter baseline 
IPSC frequency, amplitude, rise, or decay compared to water controls 
 Fig. 5.1A and B show representation baseline sIPSC traces in water-treated 
and Etoh-treated animals, respectively. There was no significant differences in 
baseline frequencies between EtOH exposed animals versus water controls 
[t(11)=0.8695, p=0.4031] seen in Fig. 5.1C. There was also no difference in baseline 
amplitude between groups [t(11)=0.9005, p=0.3871] seen in Fig. 5.1D. There was 
also no observed difference in rise [t(11)=0.7032, p=0.4965], in Fig. 5.1E, or decay 
[t(11)=1.172, p=0.2660] in Fig. 5.1F 
There was no significant difference in IPSC amplitude, frequency, rise, or decay due 
to reactivity to acute alcohol between EtOH exposed animals or water 
 Fig. 5.1G and H show representation baseline sIPSC traces in water-treated 
and Etoh-treated animals, respectively. There was no significant effect of EtOH on 
change from baseline in either frequency [t(11)=0.3285, p=0.7487] nor amplitude 
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[t(11)=0.2003, p=0.8449] seen in Fig. 5.1I and J, respectively. We also observed no 
significant change from baseline in rise [t(11)=0.9409, p=0.9267] or decay 
[t(11)=0.4822, p=0.6391] both seen in Fig 5.1K and L respectively. 
Effects of NPY exposure is currently underpowered though preliminary data seem 
promising  
 Representative traces from NPY application in water-treated and EtOH-
treated animals are shown in Fig.5.2A and B, respectively. With only n’s of 3 per 
group, it is hard to truly run stats on the data looking at the effect of NPY exposure to 
these neurons; however, the data in Fig. 5.2C and D show that, while there may not 
be a significant change in frequency with NPY application, there could potentially be 
an interesting avenue looking at change in amplitude differences between EtOH and 
water controls. It seems that the sIPSC amplitude reduction present in water control 
is not displayed by EtOH-exposed animals. Fig. 5.2E and F show no changes in rise 
or decay, respectively. 
Similar to the NPY experiment, more cell-attached recording of baseline firing are 
needed; however, preliminary data look promising 
 Representative baseline cell firing can be seen in Fig.5.2G and H fo water-
treated and EtOH-treated animals, respectively. With only 2 per group it is hard to 
make any solid statements about the baseline firing of cells from EtOH exposed 
animals vs. water exposed; however, preliminary data seen in Fig 5.2I show a 





 Our results looking at inhibitory transmission between animals exposed to 1 
cycle of binge-like alcohol drinking via the DID paradigm vs. water controls did not 
show any significant differences in baseline measures of frequency nor amplitude. 
We also did not see any significant differences between the groups’ sensitivity to 
acute EtOH when looking at amplitude or frequency. While NPY wash-on and cell-
attached experiments are still too underpowered to achieve statistical relevance 
there do seem to be promising preliminary data suggesting the possibility of effects 
in EtOH exposed animals. 
 While we hypothesized that exposure to EtOH might increase sensitivity to 
IPSC activity within this neuronal population, we did not see this effect. This could be 
due to the fact that animals only went through 1 cycle of DID exposure before 
electrophysiological recordings. In previous research showing NPY-related 
differences in IPSC characteristics, mice underwent 3 cycles of DID exposure before 
recording occurred (Sparrow et al., 2012). It is possible that longer exposure to 
EtOH is required in order to see significant changes within this population. This is 
one of the first looks at what a very brief amount of EtOH might alter in cell 
properties and adds to literature, showing that in the DID paradigm more cycles of 
exposure are necessary to significantly alter function. There is also the possibility 
that this circuit could be resistant to alterations due to EtOH consumption. It is 
known that NPY opposes the effects of EtOH and blocks that transition to alcohol 
dependence (Glipin et al., 2011). This circuit could play a large role in blocking the 
effects seen with alcohol and this transition. 
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 There is also an array of research suggesting significant sex differences in 
the function of the NPY system (Eva et al., 2020, Ip et al., 2019; Thorsell et al., 
2007). Since our data was collapsed across sex due to underpowered 
representation from each sex per group, there is the possibility that we are not 
seeing some possible significant differences in these cellular properties between 
males and females within our study. 
 Overall, this adds to literature by showing that, with the DID paradigm, longer 
exposure may be necessary when looking at EtOH-mediated differences in cellular 
function. We also see that further data collection is needed across sex and with NPY 





Figure 5.1. A brief history of binge-like EtOH exposure does not alter baseline 
IPSC characteristics in npy1r-cre mice and no significant differences between 
groups can be seen with acute EtOH exposure. A & B show baseline sIPSCs 


































































































































































































































significant differences between EtOH-exposed vs. water in regards to baseline 
frequency and D. no differences in baseline amplitude. E. No differences in baseline 
rise was observed and F. No difference of decay was observed.  G & H show sIPSC 
with EtOH application in both water-treated and EtOH-treated animals, respectively. 
There were also no differences in the change in frequency, I, or amplitude, J, with 
acute 44mM EtOH application. K and L so now change in rise or decay due to EtOH 






Figure 5.2. There could be differences in preliminary data between the 
amplitude change after NPY and there possibly an effect on cell-attached firing 
rate in the EtOH exposed animals. A & B show representative traces after NPY 
application in both water-treated and EtOH treated animals, respectively. C. There 
are no significant differences between EtOH-exposed vs. water in regards to change 
from baseline frequency D. There could be an interesting effect in change from 
























































































































































E & F (EtOH: cells n=3, animals n=2; water: cells n=3, animals n=2). G & H show 
representative traces from cell-attached firing in both water-treated and EtOH-
treated animals, respectively. I. There is also a possible effect of EtOH exposure 
enhancing the firing rate within these neurons (EtOH: cells n=2, animals n=2; water: 











 No known studies have been completed to understand the role of the circuitry 
between the CeA and the LHb in consumption of alcohol. So far, the only known 
study looking at this connection centered around depressive-like behavior 
associated with chronic pain (Zhou et al, 2019). We had found the both GABAergic 
and Y1R-expressing populations in the CeA projected to the lateral portion of the 
LHb shown in Fig. 1.1. Both NPY and GABA have interactions within the CeA 
indicating association with control alcohol consumption (Gilpin et al, 2011; Sparrow 
et al 2012). To our knowledge there is no prior investigation of these projections in 
early binge-like consumption models. Therefore, the goal of this dissertation was to 
characterize this pathway and uncover the role it plays in the binge-like consumption 
through the utilization of chemogenetic inhibition with DID, the binge-like drinking 
paradigm, as well as perform electrophysiological recordings of these projection 
neurons. 
Summary of Experimental Findings 
 In Chapter 2, we investigated the role that CeA GABAergic projections to the 
LHb played in regards to binge-like EtOH consumption. We did so by utilizing the 
cre-dependent, inhibitory Gi/oDREADD or control viral construct injected into the CeA 
while simultaneously cannulating the LHb for microinfusion of designer drug, CNO. 
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These studies were completed in vgat-ires-cre mice backcrossed with C57B6/J 
mice. CNO microinfusion before alcohol access using the DID paradigm significantly 
reduced binge-like 20% EtOH consumption only in the group who received the 
active DREADD construct and had no effect in control animals across a Latin square 
design. Further testing with 3% sucrose showed no significant effect of CNO in 
either group across a Latin-square design. Since there was no significant effect seen 
with sucrose consumption, we do not believe that this manipulation caused any 
locomotor effects in general. 
 Chapter 3 was aimed at uncovering the role of a subpopulation of these 
projection neurons in relation to binge-like EtOH consumption. Our main target was 
the NPY system and, more specifically, Y1R-expressing neurons that project to the 
LHb. Using the exact same paradigm as used in Chapter 2 in npy1r-cre mice instead 
of the vgat-ires-cre, we show that CNO infusion into the LHb onto terminals of these 
neurons in the CeA significantly blunts binge-like consumption of alcohol in the 
group with the active inhibitory DREADD construct and not in control animals. We 
did not see this same blunting of sucrose consumption. These results together 
highlight an important circuitry involved with early stages of binge-like drinking and 
seems to be specific to alcohol and not other reinforcing substance. 
 We next attempted to look at a downstream target of the LHb and the 
involvement that it may play in the effects that we saw in Chapter 3. This target is 
the RMTg, which is known to be involved in a variety of anti-reward and avoidance 
learning and behaviors and specifically does this through circuitry stemming from the 
LHb (Stamatakis and Stuber, 2012; Laurent et al, 2017; Proulx et al, 2014). We did 
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this by using two inhibitory chemogenetic DREADD constructs. The Gi/oDREADD 
construct used in the previous studies was used as, not a cre-dependent viral vector 
but, as a neuronal-dependent virus and injected this bilaterally into the RMTg while 
infusing the second inhibitory chemogenetic cre-dependent virus, KORD, into the 
CeA and cannulated the LHb as in previous studies. There were no effects of 
treatment seen within this study with either EtOH nor sucrose. There was great 
variation in the data using this paradigm and could indicate that changes to this 
manipulation are necessary to test multiplexing in a manner that causes less stress 
on the animals prior to testing. 
 Finally, in Chapter 5 we aimed to look at how a brief exposure to binge-like 
drinking of EtOH following one cycle of DID, with EtOH and water controls, could 
alter the frequency and amplitude of IPSCs in these LHb-projecting, Y1R-expressing 
CeA neurons. We also sought to uncover how this brief binge-like alcohol exposure 
would affect these measures during exposure to acute EtOH and NPY. Due to our 
underpowered representation across sex, we were unable to fully probe how female 
and males differ in these measures and thus collapsed groups and did not see 
significant differences in any baseline measures of IPSC frequency nor amplitude. 
There were also no differences between EtOH and water controls in change from 
baseline with alcohol exposure. The NPY portion of our study also remains 
underpowered; however, preliminary data may implicate a possible difference in 
NPY effects on amplitude where exposure to brief binge-like EtOH drinking may 
counteract NPY ability to reduce IPSC frequency seen in water controls. Further 
recordings are needed in order to fully understand these data and given sex 
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differences seen in NPY effects it would provide great insight to continue further 
recording in these animals (Eva et al., 2020; Ip et al., 2019; Thorsell et al., 2007).   
GABA and NPY in the CeA and Involvement in Alcohol Consumption and 
Alcohol Use 
 
Peptide interactions within the GABAergic system and Alcohol  
The GABAergic system is an important target of EtOH effects, especially 
within the CeA. Previous studies have shown that EtOH interacts with the 
GABAergic population within this region in order to enable its effects. In particular, 
EtOH is known to increase GABAergic transmission a pre- and post-synaptic sites 
within this region (Roberto et al., 2004). Our study of the GABAergic LHb pathway 
from the CeA is consistent in that, while EtOH is known to enhance GABAergic 
release, when GABAergic projections are inhibited to the LHb, it seems that EtOH 
might not be as rewarding as normal seeing that animals significantly blunt binge-
like consumption. Building off of this, previous studies also show that NPY 
decreases GABAergic transmission, opposes the effects of EtOH, and that a history 
of binge-like EtOH consumption leads to an overall decrease in NPY and Y1R 
expression within the CeA and resulted in a facilitation of NPY-induced inhibition of 
GABAergic transmission (Gilpin et al., 2011; Sparrow et al., 2012). This facilitation 
maybe due to higher receptor availability or sensitivity due to the overall lowering of 
NPY release. Our experiments from Chapter 3 follow these same concepts, where 
modulation of Y1R-expressing neurons in the CeA that project to the LHb has effects 
on binge-like EtOH consumption. Specifically, that inhibition of these neurons blunts 
binge-like consumption of EtOH. This manipulation gives great insight into this area 
 
77  
seeing the Y1R are inhibitory G-coupled protein receptors and our manipulation 
seems to mimic the same effect that would be present if NPY itself was binding to 
these neurons and thus inhibiting their activity.  
Further research shows that NPY acts to reduce EtOH consumption through 
the Y1R mechanism (Thiele et al 2002; Robinson et al, 2019). While this peptide 
acts as a protecting molecule against alcohol consumption, the CRF peptide is 
implicated to be a driver of EtOH consumption (Valdez and Koob, 2004; Kash and 
Winder, 2006). These two peptides seem to act as a balancing system that can be 
easily manipulated, especially by drugs of abuse. Within the extended amygdala, 
NPY, acting through the Y1R, is responsible for blunting binge-like EtOH 
consumption by inhibiting CRF signaling (Pleil et al, 2015). This could add insight 
into our own circuitry and leads to the possibility that this same action is being 
carried out within the CeA as well. 
Differences of NPY and Alcohol  
In a recent review, a meta-analysis of NPY and effects in animal models 
shows drastic differences in the NPY system and receptor expression between 
males and females (Eva et al., 2020). This shows specifically that many areas 
display a lower expression of Y1R in females.  A study looking at viral-mediated 
overexpression of NPY within the CeA specifically had drastic effects on reducing 
stress-induced obesity and energy expenditure only within male mice, but, not within 
females (Ip et al., 2019). Another study of overall amygdalar overexpression of NPY 
showed a reduction in alcohol consumption as well as anxiety and once again these 
effects are only apparent in male mice (Thorsell et al., 2007).  This could indicate an 
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important area of discovery for this circuitry. While we do not see sex differences in 
our effect with this circuitry, we do see an overall difference in the amount consumed 
between males and females, with females generally consuming more than males. 
This could cause differences in the effectiveness of this circuit to inhibit binge-like 
EtOH consumption as drinking continues and possibly might be more pronounced in 
females that males. 
Implication from Ethanol Intake Studies 
NPY Interneurons as a braking mechanism in binge-like EtOH consumption 
 Other researchers, examining the distribution and activity of NPY, have 
shown that this peptide is predominantly expressed within GABAergic interneurons 
(Allen et al 1986). This would imply that the LHb-projecting neuronal population that 
we manipulated within our intake studies are the target of these NPY-expressing 
interneurons within the CeA. These neurons might act as a disinhibitor of this system 
causing similar effects that we demonstrated in our studies. The overall hypothetical 
circuit is, CeA interneurons → Y1R-expresssing GABAergic CeA neurons → 
glutamatergic LHb neurons →GABAergic RMTg neurons → dopaminergic VTA 
neurons, and these VTA neurons may send further feedback to one of these 
regions, creating a feedback loop. If this brake system would be taken off-line then 
the feedback loop that exists between the LHb and anti-reward and reward circuitry 
downstream would also be affected. Hypothetically, release of this disinhibition 
would blunt anti-reward processing, a main role of the LHb and the downstream 
target of the RMTg. With this brake system taken offline, DA release would continue 
uninhibited and could actually lead to depressive and anxiety-provoked behaviors 
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that are also controlled, in part, by the LHb (Zuo et al, 2017b; Fu et al, 2020; Li et al, 
2019). The circuitry that we have manipulated within these studies acts as a middle 
character to the effect that we have shown here and could implicate a much larger 
communication loop that relies on this NPY transmission onto these neurons in order 
to alleviate stress and reduce EtOH consumption by acting in a protective manner. 
Future Directions 
Excitation of CeA GABAergic and Y1R-expressing neuronal projections to the LHb 
 In order to see if this circuit is bidirectionally involved in the binge-like 
consumption of EtOH, utilization of the GqDREADD construct instead of the 
inhibitory chemogenetic that we utilized in our studies. By doing this we would be 
able to see if driving this circuit activity may have an opposing effect on EtOH and 
cause a significant increase. This experiment would further solidify that idea that 
NPY action on these LHb projections is vital to protective effects against increasing 
alcohol consumption. This experiment could help to show that without this NPY 
inhibition even heavier consumption would be observed and could lead to further 
damage to this system as well as other affective outcomes.  
Effectiveness of circuit manipulation at later stages of alcohol use and dependence 
 Based on our studies with manipulation of the CeA→LHb, inhibition of this 
pathway both in the GABAergic and Y1R-expressing populations significantly blunts 
consumption of binge-like EtOH but not other reinforcers. Given research that shows 
changes in the NPY system and GABAergic signaling and tone within the CeA in 
dependence models and after chronic exposure (Sparrow et al 2012; Barkley-
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Levenson et al, 2016; Roy and Pandey et al, 2002; Zhang and Pandey, 2003; Criado 
et al, 2011; Bison and Crews, 2003), one important avenue of study would be to 
extend the drinking period to include a drinking history before manipulation of these 
circuits. This could add insight into how effective this circuit remains in the ability to 
regulate alcohol consumption after long term EtOH-dependent changes in the brain 
have occurred. This could be completed by completing varying amount of alcohol 
consumption before beginning manipulation of this circuit. Setting up groups into 
differing exposure schedules such as 3-, 6-, or 9-cycles of EtOH exposure through 
the DID paradigm and then testing on the last day of drinking for each respective 
group could help to discover if exposure to EtOH over an extended time would 
render the ability of inhibiting this circuit to reduce drinking ineffective and possibly 
show when this switch might happen. 
Electrophysiological studies of LHb neurons innervated by these Y1R-expressing 
CeA neurons 
 
 Another important topic to investigate would be the downstream LHb targets 
of these CeA neurons. Since we did not see significant effects of early alcohol 
exposure on the projection neurons from the CeA, this could indicate that changes 
are occurring in the downstream targets from these neurons and the LHb would be 
the prime target. One method for investigating this connection would be to patch 
onto LHb neurons innervated by CeA terminals while simultaneously stimulating the 
CeA in order to look at inhibitory effects of these neurons on the glutamatergic LHb 
population. This would be interesting to, using the above future direction focused on 
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a spectrum of alcohol exposure experience, look at how differing times and amounts 
of alcohol exposure in groups of animals could affect these downstream neurons. 
Inhibition of CRF neurons utilizing this same circuitry manipulation paradigm 
 Given the interactions of the NPY and CRF system discussed earlier, it would 
not be unimaginable that, at least a portion of, these projection neurons are co-
expressing CRF. Our IHC from Chapter 3 indicated that a subset of Y1R-expressing 
neurons within the CeA express CRF. Previous research showing that other CRF 
populations within the brain are controlled by NPY activity through Y1R provides a 
window to the possibility that this interaction could also be occurring within this LHb-
projecting circuitry (Pleil et al, 2015). By utilizing the same manipulation paradigm 
from Chapters 2 and 3 we may be able to further characterize the mechanisms that 
are at play within this circuit and their involvement in the drive of binge-like EtOH 
consumption. We would expect that the same result as seen in Chapters 2 and 3 
would be the result of this manipulation. 
Concluding Remarks 
 This dissertation and data within indicate that inhibition of both GABAergic 
and Y1R-expressing CeA neurons projecting to the LHb blunt the drive to binge 
consume EtOH. This same effect was not seen when EtOH was replaced with 
another reinforcing solution, sucrose. Further investigation of multiplexing 
techniques is needed in order to effectively collect data for interpretation and acute 
alcohol does not seem to cause electrophysiological baseline sIPSC properties of 
frequency not amplitude. It also does not seem to have an effect on the effects acute 
 
82  
alcohol has on these cells in terms of change in sIPSC frequency nor amplitude. 
NPY effects remain unknown until further studies are completed in order to have a 
sufficient sample size and are able to see true effects. These results show that the 
NPY system plays an important role in the control of binge-like EtOH consumption 
and the CeA to LHb pathway may be a key target of the NPY braking system that is 
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